ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000960.1|Azinomycin_1 # 3 # 425 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0000960.1|Azinomycin_1 	3	425	+	Loose	300	24.6386	tet(S)	40.74	3000192	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATCCTGGCCGACCTGGACATGGAGACCGGCAGGCTGACGTGGGTCAACCGCGGCGACCATCTGCCGATCCTGATCCGTGACAGCCGCTGGATCACCGACCTGTCCTGTCCCCCGGCCGGTCCCATGGGAGCCGACCTGGGCCTGTCCGTCACCGTGGCCACCGAGCAGCTGGAGCCCGGTGACCGACTGCTGCTGTACACGGACGGCATCGTCGAAGCCCGCGACAGACACGGAACGGAGTTCGGACGGGACCGTTTCGTCGACTTCATCCGCCGCCATCACTCCGGCCGGCACACCCTGCACGAGACCCTGCGCCGGCTGATGGCCGCCGTCATGGAACACCACGACGGCAAGCTCGACGACGACGCCACGGTCCTGCTCACCGAATGGCGCGGCGGCCACCAGCGCGAGCTGACCCCCTGA	ILADLDMETGRLTWVNRGDHLPILIRDSRWITDLSCPPAGPMGADLGLSVTVATEQLEPGDRLLLYTDGIVEARDRHGTEFGRDRFVDFIRRHHSGRHTLHETLRRLMAAVMEHHDGKLDDDATVLLTEWRGGHQRELTP	MKIINIGILAHVDAGKTTLTESLLYSSGAIKELGSVDSGTTKTDTMFLERQRGITIQTAITSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHALRKMNIPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQWETVIVGNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVITSKLFSPTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMYTSINGELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKSVQREKLLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRKPTVIYMERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQNAVMEGIRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTELLEPYLSFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTFFTNGRSVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH	21.84	gnl|BL_ORD_ID|1524|hsp_num:0	1553			1272	1350	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000960.1|Azinomycin_3 # 1872 # 2390 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.618	BGC0000960.1|Azinomycin_3 	1872	2390	-	Loose	550	24.2534	VCC-1	40.0	3003713	protein homolog model	n/a	n/a	monobactam; carbapenem; penam	antibiotic inactivation	VCC beta-lactamase	GTGCTGCGCCACCTTCCCCACACTCCTGAGTCTGAGGAAGACTTCTCTGACCTCGTCCGGGTCGGGCATCTTGCGGTAAGGGCGCTGATTCTGTACTTCGGCTGCAGGGGGGGACACGCTTGCAGGCCGGTGACTCTCCGATCCGCTCTCGGAGAGGGAGGAGGGCACAGCAGCGACCCCGCTCACCGCCTGAGCCAGCATCTCGAAGTCGATGTCGAGTGCTCCTCTGGGGGGGATCGCGCCCTGCTCCGAGGCTCTGACCACCAGTTCGACTATCCGTGGCGGTCCGCCGGGAACGCTCTGCATCACTGCAGTGATCGTCGCCGGTTCCTCGTCAGCGCCTCCGTACGTTTCGACCGTAATAGTCCATTTCATACTATACCTGCTATCGTCTTCTATGCGGCCGTTACCCGTATGAGACGTAGCGGCCGAGGACGCGAGCGCCCTTGGCGAGGTCACACACGAGTACTCATCCCCCCCCCGGGTCATGCGAGAGTGATTCGCATGATCCAAATGTAG	MLRHLPHTPESEEDFSDLVRVGHLAVRALILYFGCRGGHACRPVTLRSALGEGGGHSSDPAHRLSQHLEVDVECSSGGDRALLRGSDHQFDYPWRSAGNALHHCSDRRRFLVSASVRFDRNSPFHTIPAIVFYAAVTRMRRSGRGRERPWRGHTRVLIPPPGHARVIRMIQM	MKRIAMYVALSISTSTAFADEHNKNMADIEAAFEGRVGVYAINTGSGKAYSYRANERFPLCSSFKAFLAAAVLKMDQDSPGVLLEKVNYHNRTMEPHSPITEKFQSQGMAVGELAAATLQYSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLDRWELDLNSAIPGDERDTSTPKAVAESLNKLISNTVLDNYHQEIFKKWMIGNTTGDNRIRAAVPDGWVVGDKTGTCGKYGTANDHAFILQGNNAAPLILSIYTTRKGEHMKHDDEVIAKAARIAIENVK	60.56	gnl|BL_ORD_ID|2024|hsp_num:0	2227			180	240	ertapenem; meropenem; imipenem; aztreonam; doripenem
BGC0000960.1|Azinomycin_4 # 2596 # 6387 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.739	BGC0000960.1|Azinomycin_4 	2596	6387	-	Loose	1000	52.7582	almE	32.71	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCACCGCCACCAGCGCCGCAGTCCCCCAGCTCTCCCTGGAGACCGTCGCCGAGATCGCGGCCGGTACCGCCGGGGTCCGTGACGCCGCCGCCGTCCGCGACCGCCGGCTGCGCGTCACCGCCACGCGCCGCGCGGCGTCCGGTCCCGGGTCCGGCGGAGGCGAAGCGGGGCGCGGCACCGCCGTCCCCGCCGACCGTCCGGCCCTGGTTCGCGGCCCCGAGCCGGTGCTGCCGCCGGACGCCGTGCCGACGCTGCCGCAGGCGCTGGCCCGGGCGGCGCGGGTGGCTCCGGGCCGCGGCACCACCTATCTGCTGCCGGACGGCAGCACCGACCGGCAGACGTACGCCGAGCTGTACGAGGACGCCCGCCGCATGCTGGGCGGACTGCGCCGCCACGGTCTGGCCCCGGGCGACCCCGTGCTGCTGCAGTGCGCCGACAGCCGTACGTTCGTCACCGCCTGGTGGGCCTGTGTGCTGGGCGGGTTCCTGCCCACTCCGCTGGCTCCGGCGCCGGAGTACGCCACGGACAACGCCGCGGTACGCAAGCTCGCCGCCGCCTGGGACCTGCTCGGCCGGCCGCCGGTGATCGCCGATCCCGGGCTGTGCGAAGGGGTGCGTTCGCTGGCCGGCCGACTGCCTGGCGGCGAGGCGCCGCGGGTACTGGCCTCCGACGCCCTGCCCGATCCGGAACCGGCCGACTGGACCGTACCGGACCCGGACGCGCTGATCGTCAACCTGCTCACCTCCGGCAGCACCGGCACGCCCAAGTGCGTGCAGCACCGCCATCGCACGATCGTCGCCAGGAGCTACGCGGCGATCGCCGCGAACGGCTTCACGGAGCACGACGTCTCGCTCAACTGGATGCCGCTGGACCACGTCGGCGGCATGATCATGTACAACCTCCGGGACGTGTTCCTGGCGTGTGAGCACGTCAACGTACGAACGGAGTCGGTGATCCGCAGGCCGTTGCTGTGGCTGGACTGTCTGGACCGGTTCCGTGCCACCAACACCTGGGCGCCCAACTTCGCGTTCTCGCTCGTGTGCCAGCGCGCGGAGGAGATCGCCGCCGGTTCCTGGGACCTCAGCCGTCTGACCAACATCTGCAACGCCGGTGAGGCCGTCGTCGCCCGTACCGCACTCCGCTTCGTGGAACTGCTCGCCCCGCACGCACTGCCCGCCGACGCCATGGTGCCCTGCTGGGGGATGTCGGAGACGTCCTCGGGGGTCACGTACACCCGCATGCACCGTGACGACGCGGCGGTCGGCACCGTCTCCCTGGTGCCCGCCTCGCTGGACGGCGAACTGCGCGAGCTGCCGGCGGGCACTCCCGGCGCGGTCGTGGTGACCGAGGTCGGTTCCCCGGTGCCCGGTGTCGCCCTGCGCATCGTGGACCAGGAAGGAGAGGTGCTCCCGGAGGGCCGGGTCGGGCGGCTGCACGTGTCCGGCGACACGGTCCTGAGCGGTTACGCGTACAACGAGCGGGCCAACCGGGAGAGTTTCACCGCGGACGGCTGGTTCGACACGGGTGACCTGGGGTTCCTGCGTGACGGCCGGCTGTTCCTCACCGGCCGCCGGAAGAACATGGTGATCGTCAACGGGGCGAACTTCCCCGCGCACGAGATCGAGGCGGTGGTGGAGCAGGTACCCGGCGTCGTGCCCGCCTGCTCCGCGGTGGCCGGGGTGCCCGACGAGGACACCGGCACCGACGCTCTGGTGGTCTTCTTCGTGCCCGGCACCGACGACGTGCCCGCGCTGGTGGACGCCATCCGCTCGGCTCTCGCCCGCGACCTGGCCCTGCGTCCGACCTACGTGGTGCCGGTGACGTCCCGGGAGTTCCCACGGCACAACGGCGGGAAGGTGCAGCGCGAGCGGCTGCTCGAAGGCTGGCGCGAAGGCCTGTTCGACGACCGCTGTTACGGCGGTGGGACGGACGGCGTCGCACCGGACGAGGCGCCGGACTCGGAGGCCTCCGTCCCCGCGCTGGCGGTCGTGTGGGAACCGGCCGACGCACGGCTGAGGCAACGGCCGGACGGTCCCCTCGTGGCCTGTGTCAGCGGTGACGTCCCCGACTGGCTGCCCGTGTCGACCACGGCTCAGATCGTGGTCGGCCCGGACGCCGTGGAGCTGGCCTCGGCCCTGGAGCGGGCCTTCGCGACGGCCGGCGAGGGGCCCACGGACGAAGGGGCCGTACCACAGGTGCTGTTCGTCGCCGCCTCGGACCCCGCGACGGCGCCGGCCGACGGCGACGCCGGGGTGCTGTCGGAGTTCCTCGCCGTGGCGTCGGCCGTGGCGCGGATCCGCCCCGATGCCGAGCTCACCGTGCTGACCCGGGGAGCCGTGCCGGCCGCCCCGGGCGACACGGTTGTTCCGGGCCGGACCGGACTGACCGCGCTGGTGCGTACCGCGCGCTCGGAACGGCTTCTCGCCCGTACCGCACTGATCGACGCCCCGGCGGACGCCGGCGCGGCCGAGCTCGCGGCCCTGGCCACGGTGCGGCACAGCGGCGACGTGATCGCCGTGCGTGACGGCAGGCCGCTGCAACAGCGGCTGCGCGCCGTGCCGTTGCCGGAGGTCTTCGACGTACCCGCTGATGTGCTGCCCCGGGGCGGGACCTGCCTCATCACCGGTGGTCTCGGCGGCCTGGGACGAGCCGTGGCGGAGCACCTGGTGGTCACGCACGGGGCACGGCTGCTGATCGTCGGGCGGACCCCGCAGGAGCGCCTGGACACCGGGGCCCGGGAGGCGCTGGAGGTCCTGCACGCCATCGGCGAGGTCCGCTACCGCACGGCCGATGCCGCGGACCCGGACGCGCTGGCCGGGGCGGTGGCCGAAGCGGAGGCGTCCTGGGGGTGCGGCCTCGACCTGGTGCTGCATCTCGCCGGTGCCGCGGTCGCCCCGCAGTGGGAGTCCTTGACCGACCACGAACTGCGGGCCGAGTCCGCGCAGTGGCTCGCGACGATGCTGCATCCGAAGGCCGGTGGCTGTGCGGCCCTCGATGGGGTGCTGGCCACACGGCCGGACACCGCCGTGGTGCTGTACTCGTCCGTGAACGGTCTGTTCGGCGGGACGGGTTTCGGTGCGTACGCGGCGGCCAACGCGGTACTGGACGGCTGGGCCCAGCGCTGGGCCGCGGCGGGGCGACGGGCCCAGAGCCTGGCCTGGAGCATGTGGGACGGCCCGGGGATGAACCAGGGCAGTCCGCTGGTCGCGGCGGGCAGGCACCGGGGACTGACCCTGATCGACCCGACCCGGGGCACGCTGGCCCTGCTGGGCGCCCTGCACGCCGGGCCGGTACACCTGCTCATCGGCGCGGATCCGGCGAACGAGCAGATCAAGCCGCTCCTGGCGGCGGACCAATTGGGCGGCGGCACCGTCGCCGTGGCGGTCGTACCCGCGTCGGACACGGACCCTCAGCAGGTGCGGGCCGCGGTGTCGGCTCAACTGGCCGACCGTGGGATCTTCGCCCGGGTCGTGGTGACCTCACGGATAGAGCGGGACCGCAGTGGCACCCCCGACCCGGCCGCTGTACTCGCGGCCGTCGGCGCGGGCGGCGCCTCCTATCTGCCGCCCGAAGGACGGCTCGAAGCACTGTTGGCCGAGGCCGCGGCCGAGGTGCTCGGAGTCGCGCGCGTGGGCAGGGACGACTCGTTCTTCAGCCTGGGGTGCGATTCGATCAGGGCTGTGCAGCTTGCGGAGGCGCTGAGCGGGCAGCTGGACAGTCCGGTCTCGGTGGGCTCGCTCTACGAGTCCCCGACGGTCCGCTCCCTGGCGGCCAGGATCGCCGGCTGA	MTTATSAAVPQLSLETVAEIAAGTAGVRDAAAVRDRRLRVTATRRAASGPGSGGGEAGRGTAVPADRPALVRGPEPVLPPDAVPTLPQALARAARVAPGRGTTYLLPDGSTDRQTYAELYEDARRMLGGLRRHGLAPGDPVLLQCADSRTFVTAWWACVLGGFLPTPLAPAPEYATDNAAVRKLAAAWDLLGRPPVIADPGLCEGVRSLAGRLPGGEAPRVLASDALPDPEPADWTVPDPDALIVNLLTSGSTGTPKCVQHRHRTIVARSYAAIAANGFTEHDVSLNWMPLDHVGGMIMYNLRDVFLACEHVNVRTESVIRRPLLWLDCLDRFRATNTWAPNFAFSLVCQRAEEIAAGSWDLSRLTNICNAGEAVVARTALRFVELLAPHALPADAMVPCWGMSETSSGVTYTRMHRDDAAVGTVSLVPASLDGELRELPAGTPGAVVVTEVGSPVPGVALRIVDQEGEVLPEGRVGRLHVSGDTVLSGYAYNERANRESFTADGWFDTGDLGFLRDGRLFLTGRRKNMVIVNGANFPAHEIEAVVEQVPGVVPACSAVAGVPDEDTGTDALVVFFVPGTDDVPALVDAIRSALARDLALRPTYVVPVTSREFPRHNGGKVQRERLLEGWREGLFDDRCYGGGTDGVAPDEAPDSEASVPALAVVWEPADARLRQRPDGPLVACVSGDVPDWLPVSTTAQIVVGPDAVELASALERAFATAGEGPTDEGAVPQVLFVAASDPATAPADGDAGVLSEFLAVASAVARIRPDAELTVLTRGAVPAAPGDTVVPGRTGLTALVRTARSERLLARTALIDAPADAGAAELAALATVRHSGDVIAVRDGRPLQQRLRAVPLPEVFDVPADVLPRGGTCLITGGLGGLGRAVAEHLVVTHGARLLIVGRTPQERLDTGAREALEVLHAIGEVRYRTADAADPDALAGAVAEAEASWGCGLDLVLHLAGAAVAPQWESLTDHELRAESAQWLATMLHPKAGGCAALDGVLATRPDTAVVLYSSVNGLFGGTGFGAYAAANAVLDGWAQRWAAAGRRAQSLAWSMWDGPGMNQGSPLVAAGRHRGLTLIDPTRGTLALLGALHAGPVHLLIGADPANEQIKPLLAADQLGGGTVAVAVVPASDTDPQQVRAAVSAQLADRGIFARVVVTSRIERDRSGTPDPAAVLAAVGAGGASYLPPEGRLEALLAEAAAEVLGVARVGRDDSFFSLGCDSIRAVQLAEALSGQLDSPVSVGSLYESPTVRSLAARIAG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	227.16	gnl|BL_ORD_ID|4935|hsp_num:0	5928			1092	1410	colistin A; colistin B
BGC0000960.1|Azinomycin_5 # 6384 # 7205 # -1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.731	BGC0000960.1|Azinomycin_5 	6384	7205	-	Loose	200	27.335	vanH gene in vanD cluster	26.03	3002944	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	TTGAGCACGGACACCCACGCAGGGGCGTCCCCGCGCAGCGGACCGGTGAGCTTCACCATGGACTCGCCCTGGGTGCGCCGCGTCCCCCGCGAACAGGCCCGGGTACGGCTGATCTGTCTGCCGTTCGCCGGTGGCGGCGCGTCCGTGTACCAGCGGACGGCGGCACTCATGCCCTCCTGGGTGGAGACGCTGACGGTGCAGCTGCCCGGCCGTGAGGACCGCTCCCGGGAGGAGCCGCCGGCCCGCATCGAAACGCTGGTCACCGCCTGCTCGATCGCCCTGCGCCCGTACACCACCATGCCGTACGTGCTGTACGGGCACTGTGCGGGCGGGTTGCTGGCGTACGAGATCGCGCACGAGATGGGCCGCCGGTTCGGAACGTGGCCGCAGCGGCTGATCGTCGGCGAGCAGCCCGCTCCGCAGGCGCCGCCGCCTGCGGAGCCGTTGCACCTGCTCCCGGACGAGGAGCTGCTGGCGACGGTGCGCGAGCGCGGCGGGCTGCCCGACGCGGTGGCCCGCAACGCGCCGTTGCTGGACATGCTCCTGCCGCTGCTGCGCAGTGACTTCGAGCTCTGGGAGAACTACCGGCACCGGCCGCGTCCCCCGCTGCCGGTTCCGATCACCACGGTTCGGGGGCTGACCGGCTCGGTGGACGAGTCGGACCTGGCCGGCTGGGCCGCGCAGACGGCCGTGGGCCGGACCGGTCTGAGTGTGGAGGGCGGGCACTACTTCGTCGTCGGACTCACCCCGGAGGCCGCCCGGGAGATCGGTGGACAGCTGGCCGTCGAACCGCCCGCTCCGGCCGGAAGGACCTCTTCGTGA	MSTDTHAGASPRSGPVSFTMDSPWVRRVPREQARVRLICLPFAGGGASVYQRTAALMPSWVETLTVQLPGREDRSREEPPARIETLVTACSIALRPYTTMPYVLYGHCAGGLLAYEIAHEMGRRFGTWPQRLIVGEQPAPQAPPPAEPLHLLPDEELLATVRERGGLPDAVARNAPLLDMLLPLLRSDFELWENYRHRPRPPLPVPITTVRGLTGSVDESDLAGWAAQTAVGRTGLSVEGGHYFVVGLTPEAAREIGGQLAVEPPAPAGRTSS	MQEKIDITVFGCERDEAAVFRKLSSEYGVTVSLIEDVVSEHNAKLADGCQCVSVSHKAELSEQLLLALKHAGVKYISTRSIGFNHIDIQAAGQLGMAVGTVAYSPGSVADYTVMLMLMLLRGTKSVLRGTQKQNYCLNDCRGKELQDLTVGVLGTGRIGQAVMERLEGIGCKVLAYDRTHKAGANYVSFCELLKSSDIVTLHVPLAEDTRHMIGREQLEMMKREALLINTARGALVDTAALVAALKEQKIGGAALDVLEGEEGIFYHECTQKTIGHPYLSVLQKMPNVIVTPHTAYHTDRVLVDTVSNTIRNCLNFERSLGNV	84.52	gnl|BL_ORD_ID|1348|hsp_num:0	1333			516	735	vancomycin; teicoplanin
BGC0000960.1|Azinomycin_6 # 7202 # 10513 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.738	BGC0000960.1|Azinomycin_6 	7202	10513	-	Loose	1000	153.68	almE	27.5	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGTCAACAGAGCGAGCTGCTTCGCCGACTGCGCCGGCTCCCGGGGGAGCGCCGGGACGCGCTGTTGGCTCAGCTGGAGGATGTGTCCGCCGGAGCCCGGTCCGCCCCCCTGTCCTACCGGCAGGAGCAGCTGTGGCTGTTCGACCGGTTCGCCCCCAGCAGCCTGGCCTACGGGCTCGGCTTCGCCCTCCCGATCGAGGGCCGGCTCGACACGGAAGCGCTGGGCGCGGCGCTGGCCGATCTGCTGCAGCGCCACACCGTGCTGCGCTCGACGTTCTCCGACGAGGACACCCGGGGCACCCAGCGGCTGAAGCCGGTGCCCCGCATCCGTCTGGAGACCGAGGACGTTCCCGCCGAGCGGTTGCACCCGCGCGCCGACGAGGTGGTGCAGGGCGAGCTGCGCCGGGGATTCGACCTCAACTCCGGCCCGATGGTCCGTTTCCGGCTGCTGCGGTCCGCCCCCGACCTGCACCTGCTGGTGCTGACCAGCCACTCCATCGTCCTCGACCCGCGCTCCGCACGCGTGCTGCAGGGCGATCTGGCCCACGCCTACCGCGCCCGGGCGGCGGGCGCAGCGCCGGCCTGGGCGCAGGATCCGGTGGAGTTCGGTACCTACGCGGCCTGGCAGCGGGCCTGGTGCGAGCAGGACGCCGCCCGCGAGGCGACCACCTACTGGCGTGACGCCCTCGCGGGCTGGGAGAGCACCGAGCTGCCCACCGACCTCCCCCGTCCGCGGCTGATCGACCTGAGCAGCGACGTCGTCCGGCGGCCGCTGCCGCCCGGACTGGCGGCGGCCGCCGACGACTTGGCGACCGGGAGCGGCGCCGAACGGCGGGACGTCCTGCTGGCCGCTTTCCTGGTCGTGATCGCCCGCCACACCTCCCGGGGCGACCTCACCATCGGACTTCCCCAGGACGTCGCGGGCCCGTACGACGAGAGCCGACTCGTCGGTGACATCGGAAACCTGCTGCCGCTGCGGGTCGAACTGGACGAGGCGGACAGCTTCGCCGCCGTGGTGGCCCGGGTGCGCGACGCCCGGCGGGACGGCCTGCACCACGCGAGTCTGCCGTTCAAGCTGATCCTGGACGCACTCGGGGTGGAGCCCGACGCCGGCCGGCTGCCCCTGGTACAGATCGGCTTCACGACCCCGGTCGCGGGCGGCGGACCGGCCGAGGCCGACGGGGTGCGCTTCGGCTGCGAGCAGATCGACGCCGGGTCCGGCGCGTTCGAACTCGCGCTGGAGGTCACGGACGGTGAACAGCCCACCGTGGCCGTGCGGTTCGCCACCTCTCTCTACCGGCGGGCCACGGCCACCCGCGTCCTGGACCGTTTCCTGCAGACCCTGGACGCGCTCTGCCGACAGCCGCGGCGTCCCCTGGGAGACGCCCCGCTGGGCACGCCGCAGGAGCACGCCGACGTACGGGAGCGCTGGAACGAGCCGATCGGCGCGCCTGCCGACACCCCGCTGCACGACCTGTTCGCCGAGGTCGTCGCGGCGGCTCCGGACAACACCGCGCTGCTGTGGAAGGGCGGCTCCCTGTCCTACGGCGAACTGGACGCCTGGTCCTGGCGGATCGCGCGGCGGCTGACGGCCGCCGGGGTGGGGCTCGGCGACCTCGTGCCGGTGGTGATGCAGCGGGGCCCGGCCCTGCTCGCCGCCGTCCTCGGTGTCCTGCGGGCCGGGGGCGCCTACGTGCCGGTGGACGCCGGCCAGCCCGACGAGCGGCTGGCGATGATCCTGGAGGACACCGGGGCCAGGACCGTGGTGGTCTCCCCCGGTACGGCGGACCGGGTCCCCGGTCCGCTGGCGCTGGTCGTCGGTGCCGATCCGCTGGACGGACCGCAGGCGGAGGAGGAGCCGCCTGCGGTCGTCGTGCCGGCCGCCTCCGCGGCGTACGTCATCTACACCTCGGGGTCCACCGGCCGTCCCAAGGGGGTGGTGGTCGAGCACCGCAACGCGGCCAACTTCACCCGCACCGTCCGGGACATGTTCGACCTCACTCCCGAGGACCGGGTCCTGCATTTCGCCTCCCCCGGCTTCGACGTCTCGGTGTTCGAGATCTTCGGAACCCTGCTCAGCGGCGCGGTCCTGTACGTACTGGACGAGGACCAGCGGCGCTCCGTGGACGCCCTCGACGCAGTCCTGCAGGAGCAGCGGATCACCGTCATCGACCTGCCCCCGGCGATCATGGATCTGCTCGCTCCCGAGAACTATCCCGACCTGCGGGTGGCGTTCGTCGGGGGCGAGGCGTTCACCGGCGAGCTGACCACGCGGTGGGCCCGTGGCCGGAGCTTCTGGAACGGGTACGGCCCGACGGAGACCACGGTGACCGTGGTGGCCAAGCGATGCGAGGGCGAGTGGACGGCCTCGCCGCCGATCGGCCGGGCGATGGCCAATCACCGTGCCTACGTGGTGGACGGCGCCGGTGCGTCGTTGCTCCCGGCCGGCGCGGTCGGTGAACTCGCCATCGCCGGGCTGGGCGTGGCGCGCGGCTACCTGGGCCAGCCCGCCCTCACCGCCGACCGGTTCCGGCCGGACCCCGACGGGCCTCCCGGTTCCCGCCGCTACCTCACCGGTGACCTGGCCGTCTGGGACGAGGCAGGGGACCTGTGCTTCGTCGGCAGGGCCGACCGGCAGGTGAAGGTCCGCGGCGTGCGGATCGAGCTGGGCGAGGTGGAGGCCGCGCTGCAGGCGGTGGACGGAGTCGCCCAGGCGGTGGCGGAGGTGGCGACCGATCCGCGCACCGGCGCGCTGCTGGTGGCGTACGTGGTGCCGGAGCGTCCCGGCGAGCTGCAGCTGGACACGATCCGCTCCGCGGTGGCGCGCCGGCTGCCGGCCGCGATGGTCCCCTCCGTCCTGGTGCCGCTCGACGCGGTCCCGCTGACCCCGAGCGGCAAGATCGACCGACGGCGGCTGCCCGCCGTGGAGTTCGCCGTGGTGGACGAACTCTCCGAGGCCGACGAGGAGAACAGCACGCCCACCGAGCGCACGATGCGCGAGGAGGTGTTCACCCCGCTGCTGGGCGCCCGGATCGGCAATCACGTGAACTTCTTCGCGGCGGGCGGCACCAGTCTTCAGGCGATCCAGCTGTCCTCCCGCGTGAACGCCGTGTTCGGGGTGGCCCTGCCGATCGCCGACTTCTTCGCCACTCCCACCGTGGCCGGTCTGGCCGGGCTCGTCGACGCGGCGCGTTCGGGCCAGGAAGCGCGGCGGGACGCGCTGGCGGAGGCCCTGGACCTGGTGGAGGGGAGCAGCGACGAGGAACTCGCCGAGCTGGCCGCCTCGCTGGACGGGGAGGGGACGCGTTGA	MSQQSELLRRLRRLPGERRDALLAQLEDVSAGARSAPLSYRQEQLWLFDRFAPSSLAYGLGFALPIEGRLDTEALGAALADLLQRHTVLRSTFSDEDTRGTQRLKPVPRIRLETEDVPAERLHPRADEVVQGELRRGFDLNSGPMVRFRLLRSAPDLHLLVLTSHSIVLDPRSARVLQGDLAHAYRARAAGAAPAWAQDPVEFGTYAAWQRAWCEQDAAREATTYWRDALAGWESTELPTDLPRPRLIDLSSDVVRRPLPPGLAAAADDLATGSGAERRDVLLAAFLVVIARHTSRGDLTIGLPQDVAGPYDESRLVGDIGNLLPLRVELDEADSFAAVVARVRDARRDGLHHASLPFKLILDALGVEPDAGRLPLVQIGFTTPVAGGGPAEADGVRFGCEQIDAGSGAFELALEVTDGEQPTVAVRFATSLYRRATATRVLDRFLQTLDALCRQPRRPLGDAPLGTPQEHADVRERWNEPIGAPADTPLHDLFAEVVAAAPDNTALLWKGGSLSYGELDAWSWRIARRLTAAGVGLGDLVPVVMQRGPALLAAVLGVLRAGGAYVPVDAGQPDERLAMILEDTGARTVVVSPGTADRVPGPLALVVGADPLDGPQAEEEPPAVVVPAASAAYVIYTSGSTGRPKGVVVEHRNAANFTRTVRDMFDLTPEDRVLHFASPGFDVSVFEIFGTLLSGAVLYVLDEDQRRSVDALDAVLQEQRITVIDLPPAIMDLLAPENYPDLRVAFVGGEAFTGELTTRWARGRSFWNGYGPTETTVTVVAKRCEGEWTASPPIGRAMANHRAYVVDGAGASLLPAGAVGELAIAGLGVARGYLGQPALTADRFRPDPDGPPGSRRYLTGDLAVWDEAGDLCFVGRADRQVKVRGVRIELGEVEAALQAVDGVAQAVAEVATDPRTGALLVAYVVPERPGELQLDTIRSAVARRLPAAMVPSVLVPLDAVPLTPSGKIDRRRLPAVEFAVVDELSEADEENSTPTERTMREEVFTPLLGARIGNHVNFFAAGGTSLQAIQLSSRVNAVFGVALPIADFFATPTVAGLAGLVDAARSGQEARRDALAEALDLVEGSSDEELAELAASLDGEGTR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	198.38	gnl|BL_ORD_ID|4935|hsp_num:0	5928			144	1629	colistin A; colistin B
BGC0000960.1|Azinomycin_7 # 10796 # 11548 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGCGG;rbs_spacer=13bp;gc_cont=0.720	BGC0000960.1|Azinomycin_7 	10796	11548	-	Loose	50	28.1054	vanY gene in vanF cluster	31.37	3002958	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGGAGCCCCGTCAGCGGCGCTGGTTCCTGCGCGAGCCGTCGCCCGACGCCCGGATGCTGCTGCTGTGCATGCCGTACTCCGGGTGCGGCGCCTCCATGTACCGGGCCTGGCCCGCCACCATCGGTGAGGCGGAGGTGGTCCCGCTGCAACTGCCCTGGCGGGAGAACCGGATGCGCGAGCCGCACTTCGGCACCTACGAGGAGCTGGCCGCCGCGCTGCTGGACGACGTCGGGGAGCTGCTGACCTCCCGGCCCTACGCGCTGTTCGGGCACTGCGGGGGCGCCCTGCCGGCGTTCGAGACGGTGATCGGGATCGCGGAGCGCGGGCTGCCCGCGCCGGTGCGGTATTTCGTGTCGAGTCAGGTGGCTCCGCAGGACGGTCCCTGGGGTCGTTTCCTCGGGCTGGACGACCAGGGTCTGCGGGACGAGATCGCCGGGCTGCTGACCGCGATGGGCGCCGCCGCCTCCGCCGACGAGCTCGTCGACCTGTTCATCGACGTGATGCACGCCGATCTGGAGGCCAACCGGAAGTACTTCCGTCCGGCCGGTACGGTGCCCTGCCCCATCACCGCGCTGGGCTGGGACGACGATGTCGAGGTACCGCACCGTCTGATGGGCGGCTGGCAGGCCTGGGCGCCCACGGACAAGGTGGTCCTGCCGGGGACCCACTACACCTTCCTGGACGCGCCGTCCGCGCTGGTCCGGGTACTGGCGGACCGTCTCACCCTCGGCTCCGGCTCCCTCGCGCCGTGA	MEPRQRRWFLREPSPDARMLLLCMPYSGCGASMYRAWPATIGEAEVVPLQLPWRENRMREPHFGTYEELAAALLDDVGELLTSRPYALFGHCGGALPAFETVIGIAERGLPAPVRYFVSSQVAPQDGPWGRFLGLDDQGLRDEIAGLLTAMGAAASADELVDLFIDVMHADLEANRKYFRPAGTVPCPITALGWDDDVEVPHRLMGGWQAWAPTDKVVLPGTHYTFLDAPSALVRVLADRLTLGSGSLAP	MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS	85.32	gnl|BL_ORD_ID|1808|hsp_num:0	1899			294	447	vancomycin
BGC0000960.1|Azinomycin_8 # 11548 # 12585 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.719	BGC0000960.1|Azinomycin_8 	11548	12585	-	Loose	400	28.8758	Erm(30)	24.09	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCCGCCGGTTCCGGCTCCGGGACGCCTCCCGGCACCCCGCCTCCGACCCTGCTGACCGACCTGGCGACGGGGCTGTGGAAGACCCAGACCCTGACCGCGGCGATCGAGACAGGCCTCTTCGAAGCCCTGGCCGCCGGCGACGCCGACGCTCCCGAGACGGCGCAACGGCTCGGCATCGGCAAGCGGCCGGCCGAGATCCTGCTGACCGCGTGCACCGCGCTCGGGCTGCTGGAGCAGCGGGACGGGCGCTATCGGAACACCGCCGTCGCGGCGCACTACCTGGTGCCCGGCCTGCCCGACTACTTCGGCGGTTACGTGCAGATGGTGGCCCGGTACACCGCGCCGGGGTGGCTTCGGGCGACCGAGGCGGTACGCACCGACGCCCCCACCAAGCCGGTGCCCGACCCGGACCGGAACATGTTCGAGGAGGGCAACCGGCCGGAGTCCTTCTGGGAGGGGCTCTTCACCTTCTCCACCCTGACCGCCCGCCAGCTGGCGGCGTCGGTGGACCTCTCCGGTGTCCGCCGGATCATGGACGTCGGCGGCGGCGCGGGCGCCACGCTGATCGAACTGTGCCGGCAGCACCCGCACCTGAGCGGCACCGTCGTCGACCTGCCGCACGTGTGCGCACTCGCCGGCGAACGCATCGCCGCGGCCGGTATGACCGGACGCATCGACACGGCCGCGGCCGACTTCTTCGCGGATCCGCTGCCCTCCGGGCACGACGCCGTCCTGCTGTCGATGATCCTGCACGACTGGGACGAGAGCCAGAACCGGAAGATCCTCGCCTCCTGCCTGGACGCGCTGCCCTCCGGCGGCACCGTCCTGATCAGTGAGCTGCTGGTGGACGACGACAAATCCGGCCCGGTGGACGCGGCGCTGATGAGCATGAACATGCTGGTGGGCACCTGGGGACGGAACTACACCGGCGCCGAGTACACCGACTGGCTGCGCGACGCGGGCTGCTCCGAGGTGCGCACGGTCCGGTTCGCCTCACCGGGGGCGAACGGTGTGGTGGCGGGGGTGAAGGCATGA	MAAGSGSGTPPGTPPPTLLTDLATGLWKTQTLTAAIETGLFEALAAGDADAPETAQRLGIGKRPAEILLTACTALGLLEQRDGRYRNTAVAAHYLVPGLPDYFGGYVQMVARYTAPGWLRATEAVRTDAPTKPVPDPDRNMFEEGNRPESFWEGLFTFSTLTARQLAASVDLSGVRRIMDVGGGAGATLIELCRQHPHLSGTVVDLPHVCALAGERIAAAGMTGRIDTAAADFFADPLPSGHDAVLLSMILHDWDESQNRKILASCLDALPSGGTVLISELLVDDDKSGPVDAALMSMNMLVGTWGRNYTGAEYTDWLRDAGCSEVRTVRFASPGANGVVAGVKA	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	102.68	gnl|BL_ORD_ID|1123|hsp_num:0	1224			93	468	narbomycin; methymycin; pikromycin
BGC0000960.1|Azinomycin_9 # 12587 # 13792 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.705	BGC0000960.1|Azinomycin_9 	12587	13792	-	Loose	2000	26.5646	oqxB	31.71	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCACCGAAGCCGCGGACGCCACCGACCGGCTGGTGACCGCTTTCGACCACCACGACCCCGGATACACCCCGCGGACCGCGGAGCGGATCAACACGGAGATCCGTGAGCGGGGGGTGACGTGGTCACCGGCGTACGGCGGCATCTGGATACTGTCCCGGTACGCGGACGTGCGCGCCGCCCTGACGGACTGGCGTACCTACAGCTCGGCCCGCGGCGTGCACTTCCCGCGCGCCGAGGGGATGCCGATGTTCTCACCCATCGACTACGACCCCCCGGCGCAGCGCGGGATACGTGAGCGGATGGCCGCTCCGATGACGGGCGACGCCGTCTCCGCGATGGTGCCTGAGCTGCGCCGCATGGTCGCGCGGCTGCTCGCGCCGCTGGCCGGGCGCGGCCACGGGGACCTGATGGCCGAGTTCGCGGAGCCGTTCGCCATCGAGGTGCTCGGAGTGGCCTTCGGGCTTTCCGAGAGCTGCCGCGCCCGGATCCGCGAGGCGACGCGGACGATGTGGACCTACATCTCGGCCGACCGGGACGCGAGCAAGTTCTGGCCCGCCTTCCACGCCCTGCTGGCCGAGGAGGTCGAGCGGGTGCGCGACGAGCCGGACGGCAGCTATCTCGCCCGGCTCGCGGCCATGCGGCGGGACGGTTCGCCGTTGCCGGACGAGGAGCTGTACTCGATCATCGTCAGCTTCTGCGTCGCCGGGCACGACAACACGATGAACTCGATCACCCGCCTCGTGCACACGCTGGCCCAGGATCCCGCACTCCAACTGAGGCTGCGCCGCGAGCCGGAGCTGCGCCCGGCCGTCGCGGAGGAAGCCCTGCGCCGCTGGTGTCCCACCGACCGGTTCACACGGGTCACCACCCGTGAGGTCACCGTCGCGGGCACCGTCATTCCGGCGGGTGCCCGGGTGGTGCTCCTGTTCGACGCTGCCAACCGGGACCCGGAGAAGTTCCCGGATCCCGACACCTTCGATCCCGACCGCGGCAACTCCCATCAGCACCTCAGCTTCGGGCACGGCATCCATCACTGCATGGGGGTGCACCTGGCCCGCGCCGAGTTCGCCGCCGTGCTCGACGAACTGTCCCGGCTGCCGCTGTTCGACCTGGAGCAGCCGAGCGACCTGCATTTCGAGAACGGTCGGCACATCATGTTCGACCGGGTGTCGGTGCGGTTCCGCACCGGAGAGGAGCACTGA	MTTEAADATDRLVTAFDHHDPGYTPRTAERINTEIRERGVTWSPAYGGIWILSRYADVRAALTDWRTYSSARGVHFPRAEGMPMFSPIDYDPPAQRGIRERMAAPMTGDAVSAMVPELRRMVARLLAPLAGRGHGDLMAEFAEPFAIEVLGVAFGLSESCRARIREATRTMWTYISADRDASKFWPAFHALLAEEVERVRDEPDGSYLARLAAMRRDGSPLPDEELYSIIVSFCVAGHDNTMNSITRLVHTLAQDPALQLRLRREPELRPAVAEEALRRWCPTDRFTRVTTREVTVAGTVIPAGARVVLLFDAANRDPEKFPDPDTFDPDRGNSHQHLSFGHGIHHCMGVHLARAEFAAVLDELSRLPLFDLEQPSDLHFENGRHIMFDRVSVRFRTGEEH	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	38.19	gnl|BL_ORD_ID|2152|hsp_num:0	2400			2847	2970	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0000960.1|Azinomycin_10 # 13873 # 15756 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.736	BGC0000960.1|Azinomycin_10 	13873	15756	-	Loose	1000	60.8474	almE	25.8	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGATCCGCCAGCAGGACGCTCCGGCCGTACCCGGGGCCGGGCCGGCCACCACGGTGGTCTCCCGTATCGAGCTGTTCGCCCGCGACACCCCCGATGCCCCCGCGGTCCGGCACGGCGAACGGGAGCTGACCTACCGGGACCTGGACCGGCGTGCCGGGCAACTCGCCTCGGAGCTGGTCGAGTCGGGAGTACGACATGGCGACATGGTCGCCATGTACCTGGGCCGCTCCATCGAGTGGGTGGTCGGCATGCTCGGCTGCCTGAAGACGGGCGGTGTGTGCATGCCGCTGGACCCGGCCGTACCCGCGGAACGGTTCGACCGGGCGGTCGCCGCGGCGCGCCCCGCGGCCGTCGTGACCGCGGTTCCCGGCCGTGGTACGGGCAACCCCCTGCCCGCACTCCCCGCCGGGCTGCCCGTGGTCACCCTCGACGCGAGCGCTCCGCTCCCCGCAGAGACACCCGGCGGCGGACTCGCCCCGCGTGCGCAACCACGGTGCGAGGACCTCGCGTACGCGATGTTCACCTCCGGTTCCTCCGGTGAGGCCAAGATCGTGCTGGCCCAGCACTCCTGGCTGGCGCTCAGCGCCGCCCGCAGCGCCGCGGTGAACGCCACCACCGCCGCCGACCGCGGTTCCTGGCTCGGCGCGGCCGGCGCCGGGATCGCGCTGCACGAGGTCGGCGGTCTGCTCTGGCAGGGGGCCCAGCTCGTGATCGGCGACCACGAGGTGATCGCGTCACCGCCCGCCCTGCGGGACTGGCTGCTCGCCGAGCGGATCACCCAGAGTTTCGTGATCACCCCCGTCGGCGAGGTCCTGCAGAATCTGCCCTGGCCGCGCGAGTGCGCGCTGCGGCTCCTCACCCTGGGCGGTGACCGGCTGAACCGGTGGGGGCCCGCGGACCTGCCGTTCGAGGTCGCCGTCTCCTACGGCAGCCTGGAAGCCTTCCAGATAGCCAACTCGTGCCATCCCTGGTCCCAGAGGTGCACTCCCGCCACGGCCACCGACGCCGACCGCGCCAGCGCCCCGCCTGTCGGCCGGCCGATCGCCGGGGTCACCGTCCACCTGCTGGAGGACGACGGCCTGACACCGGTCGTCGACGGGATCGGCGAGGTGTGGATCGACTCGGACTGCCTCAGTCTCGGGTATCTGGGCGATCCGGCGCAGACCGCGGACCGGTTCCGGCCCAACCCGTTCGGCGCCGCGGGCAGCCGCATCTACCGCTCGGGCGACGCGGGCAGGTTCCGTCCCGACGGGATCCTGGAGCACCACGGCCGGATCGACAACATCGTGAAGATACGCGGCCACCGGGTGGAGCTCGGGGATGTCGAGTGGGCGCTCGGGCAGCACCCGGACGTCGACCAGGTCGCCGTGGTGGCGACCTGGGACGGCGACCAGCGCCGCCTCGTCGCCTGCTTCGTCGCGGCACGCGAGATCGCGCCGCTGGAGCTGCGCGACCACGCGGTGGAACGGCTGCCGGACTGGATGGTCCCGGTCGCGTACGTGCAACTGGACGAGTTCCCGCTGAACACGTCCCGCAAGATCGACCGCCGCAGGCTGCCCCCGGCCGACTGGTCCCGGGGACGTCCGTCGCGCCCCTGGCGGGCACCCGCACCCGGAGCGCAGACCGAGCTGGCCCGCCTGTTCGCGGATCTGCTGCAGGTGGACCGGGTCGGAGCCGACGACCACTTCGTGGAACTCGGCGGCGACTCCCTGCTGCTGGCCCGGTTGCAGAGCAGGATCGAGCAGCGCTTCGGCGTCCGGATCGAACTGCCGGACCTGATGGCCGGCCCGACCGTCGTCGAACTGGCCGGACGCATCCCGGGGGCCACCGCCGGGCGCACCGGCGCGGCCGCGCTGCCGCCCATCGTGCCCCGGCGCCGCTGA	MIRQQDAPAVPGAGPATTVVSRIELFARDTPDAPAVRHGERELTYRDLDRRAGQLASELVESGVRHGDMVAMYLGRSIEWVVGMLGCLKTGGVCMPLDPAVPAERFDRAVAAARPAAVVTAVPGRGTGNPLPALPAGLPVVTLDASAPLPAETPGGGLAPRAQPRCEDLAYAMFTSGSSGEAKIVLAQHSWLALSAARSAAVNATTAADRGSWLGAAGAGIALHEVGGLLWQGAQLVIGDHEVIASPPALRDWLLAERITQSFVITPVGEVLQNLPWPRECALRLLTLGGDRLNRWGPADLPFEVAVSYGSLEAFQIANSCHPWSQRCTPATATDADRASAPPVGRPIAGVTVHLLEDDGLTPVVDGIGEVWIDSDCLSLGYLGDPAQTADRFRPNPFGAAGSRIYRSGDAGRFRPDGILEHHGRIDNIVKIRGHRVELGDVEWALGQHPDVDQVAVVATWDGDQRRLVACFVAAREIAPLELRDHAVERLPDWMVPVAYVQLDEFPLNTSRKIDRRRLPPADWSRGRPSRPWRAPAPGAQTELARLFADLLQVDRVGADDHFVELGGDSLLLARLQSRIEQRFGVRIELPDLMAGPTVVELAGRIPGATAGRTGAAALPPIVPRRR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	112.77	gnl|BL_ORD_ID|4935|hsp_num:0	5928			579	1629	colistin A; colistin B
BGC0000960.1|Azinomycin_11 # 15839 # 17017 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.701	BGC0000960.1|Azinomycin_11 	15839	17017	-	Loose	800	51.2174	mef(B)	25.89	3003107	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGTCGCGCTGCCGCTGCTCGCCGTCATCACCTTCGGCGAGGGCGCGTTCGGGGTCGGCATGCTCATCGCCGCCCAATGGGTTCCGTTCGTCGTGCTCGCGCCGCTCATGGGGGTGTTCACCGACCGCCTGAACCGGCGGATGCTGATGCAGCTGTCCAACGCGGTCCGCTTCGTCGTCCTCGGCTCACTGCCGCTGGCCTGGGCGCTGGGCAACCTGACGATGGTCCACCTGTACGCGGCCGCGCTCGTCAAGGGCGTCTTCGACGTCGTCTTCCAGCTCGCCTACCAGGCCTACCTTCCGCAGCTGCTGGCGCGCGAGGACCTGGTGGACGGCAACGCCAAGACGCAGCTGAGCCGCTCGGTCGCCCTGATCTTCGGACGCAGCGGTGGCGGCGCGCTGGTCAGCGCACTCGGCGCCGCGCGGGCGATCACCGTCGACGCCGTCTCCTACCTGCTGGCGGCCATCGCGCTGGGTTTCGTACGGTTCCGTGAGCCCGAGAAGCAGCAGACCGCGCGCGGTCTGAGCGCCACGCTGGCCGACCTGCGTGGTGGCATCACCATGACCTTCGGCAACAGACTGCTGCGGTATCTGACGCTGATGGCCACCTTCGGCAACACCGCCGTGTCCATGGTCCTCGCGATGATCATCGTGTTCGGGTACGACGACCTGGGACTGAGCGCGGCGCAGGTCGGGCTGACCCTCGGTGTCGGTGGCGCCCCGGTGGTGGTCGGCGCGATCCTGTCCCGCCGGATCAACGAGCGGCTGGGCATCGGCCGCACCCTGCTGATGACCCACTCGATGCTGGTGGTGGCGTTCGCCCTGCTGCCCGTGTCCCAGGCCGGCGGGACCGGGTTCGCCGTGGCCGTGCTGATCGTCTCCCAGGGCATCTCGTCGTTCACCACACCCGTGGGGAACGTCGGGGTCATGACCCTCATCCAGAAGGCCACGCCGCCGCAGGCGATGGGCCGCGTCGGCGGCGTCTCCCTGCCGCTCGTCTGGGGCGCCAACGCCGTCGGCCCGCTGCTGGGCAGTGCCGTCGCCGTGACGGCCGGCAACAGCGCCGCCTTCTACCTGGCCTCCGCGCTCGCCCTGTGTGCCGTGCTCTGGATCCTGGCCGGTTCGGTGACCCGGCTGACCGACGACGTACCGGAGGACATGCGACTGGTCGTCGGCTGA	MVALPLLAVITFGEGAFGVGMLIAAQWVPFVVLAPLMGVFTDRLNRRMLMQLSNAVRFVVLGSLPLAWALGNLTMVHLYAAALVKGVFDVVFQLAYQAYLPQLLAREDLVDGNAKTQLSRSVALIFGRSGGGALVSALGAARAITVDAVSYLLAAIALGFVRFREPEKQQTARGLSATLADLRGGITMTFGNRLLRYLTLMATFGNTAVSMVLAMIIVFGYDDLGLSAAQVGLTLGVGGAPVVVGAILSRRINERLGIGRTLLMTHSMLVVAFALLPVSQAGGTGFAVAVLIVSQGISSFTTPVGNVGVMTLIQKATPPQAMGRVGGVSLPLVWGANAVGPLLGSAVAVTAGNSAAFYLASALALCAVLWILAGSVTRLTDDVPEDMRLVVG	MNRIKNWKKQFAVIYTGQAFSILGSAAVQFAVIWWLTIQTESAITLTIASLVAFLPNMLIGPFAGVWIDRYNRRTVMILADGLVAVSSIILGAAFLLVETPPIWFIYIVLFLRGLGNTFHGPAMQAAIPMFVPADMLTKAGGWGNMIQSISNMMGPVLGAALMSFLPISSIMIVDILGAAFAIVCLLFVIIPDITQTNEKMSVLSDMKQGFIAMKANKPLMAVFSPMLLMTILYMPLGSLFPLLARSHFMGEAWHNSIVEFVFAGGLLLSSLVIGVWGGMKRRFFMASLAIGLMGLATLISGALPTSGFWIFVICCFFLGASGTFMNVPVMAYVQESIAPEMMGKVFSLLMTAMTLSMPIGLLVAGPVVEVIGVNTWFFWSGVALIVNAVLCRILTRRYDKVTMKPQVD	95.84	gnl|BL_ORD_ID|1198|hsp_num:0	1198			162	705	
BGC0000960.1|Azinomycin_12 # 17079 # 20888 # 1 # ID=1_12;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.723	BGC0000960.1|Azinomycin_12 	17079	20888	+	Loose	710	28.1054	tet(35)	41.18	3000481	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGCGGAACAGGACGGAGCGCGGCTTCGTGCTCGTGCCACCCGTGGGGGCGGACGTGTCGCCGGACGGTTCCGGCGGCGATGTGGGCGAGACCTCTGCCCCGGCACTTTCTGACGCTGCCGGAGTGGTCCCCGTCCCGGATGACGAGTTGGTCGAGGTCATGCCCTGTGGCTCCTCATTGCAGGAATTCGGTGCGAGACGCCGTGTCCGGTCGGGTGCTGGCAGACGAACTCCCTCAACGCACACCACAATCGACGACGGCGTCACATGCGGCCAGGCTGAACCGTACATTCAGTCTGCATCGGGCATCCAGTCCTTCCGCAGAGTCGGCACGTATGACGAGATCACCCGACCGGATCGGATGGGCAAGTGGCTTGAAGACAACCCTCCGCCCCCGGCGCGCCCCTGGGCAAGTGTCTGCGCGTCACGATATCGTATGTCCATGAGAGACTACGAAGACTACATGCCCCTAGCGGTCATCCAGGAGCACTTCTGGTCCTCGGACGGATCGGCAACGGAACAGGCCCCGCTGACCGAGTGCGTGGCGCTGGCGGTGCGGGGCCCACTGGACGCGGCCGCTCTGCGCACGGCGGTCGGCGCCCTGCTGTCCCGGCACGAGATCCTGCGCAGCGCGGTACGGCTGCACGACGGACAGCCGAGCCAAGTGGTGCTCCCCGTGCCCGAGCGGCTGCCGTTGACGATCACCACTCTCCCCTCCCCGGACCGGGACGCGGACGCACGTCAGGCCCGGGACCGGGAACTGTCCCGGTTCGCCGCGACCGGGATCGACCCCGCCGCCGGATGCGGGATCGCGTTCCTGCTGCTGCGCGACAGCGACCCGGCGGGCGAGGACACCCTGGCCCTGGCCGTGCACCACATCTTCGCGGACGCCACCGCGGTCCGGCTCCTGCTGTCGGAGCTGGCCGCCGACTACGACGCCGCGCTCGCCGGGGCCCCCTCACCGGTACCCGAACCCGAACTCCAGTACGGCGACTTCACCCAGTGGGAACATGCCTCGCTGCTCCCGGCCGTCCAGGAACCCGACACCGCGTGGTGGCGGGAGACCCTGCGTGACGCGCCCACCGCCCTGGACGTCAGACCGGACCGCCCGCGCCGCCGTGTCCGCCGAGGCGCCGGCCGACGCGTCGGCCTCGTCCTGCGGGGAGTCGACGGACCCGCCGTGCGGAACACCGCACGGACCCTGCACGCCTCGCCCTACGCCCTGTGCCTGGCGGGCTGGGCGGCCATGATCACCCGCTCCACCGGTGACACGGACCTGATACTCGGCGTACTCGCGGCCAACCGGACCGTTCCCCAGCTGGAGCCGCTTGTCGGGCAGTTCGCCAACACCGTCCCGCTGCGGCTGGACCTGGCGGGCGCACCGGACCTCGCCGACGCGGTGTCCCGCTGCTCGGCCGCGGTGGCCGCCGCCGTCGAGCACGGCAGGCTGCCGTTCAACCGGATCGTGCGGGCCGCGGCCGCCCCGCGCCCGACCGACCGGCCCCCGCTGATCCAGCACATGTTCATGCCGCGCGTGGACGCCGTCGGCGAACTGACCCTGGGGGGACAGCCGGTACGGACCCTGGACGTCGAACGCGACCGCGGCCGCTTCGACACCGTCGCCGAGATCGACGTCACCGGCGACCAGGTCCGGTTGTGGCTCGAGTACGACAGCGACCTCTACACCCCGGACGGGATACACGCTCTGGTGGACGACTACGCGGGGGTGCTGCGGCAGTGGCTGGCCCGGCCCGCGCTGCGCCTGCCGGAACTGGAACTGAGCGCACCGGAGCCGGCCGGTCTCGCCTTGGACGACCGGGAGCCGGCCGACGGGAAGCCGGCGGAGGAACTCCGGGTGGACCTGCCCGGCGGCGGAGCCGTCACGTTCCTGCTCGACCGCTCACCCGGACCCGAGTACCGGCCCGTCCTGGCCGGACTGCGCGGGGCCCGGGCGGAGGACCTGGAGCTGCGGCCCGGAGGATCCGTGCATCACCCCACGGACCTGCTGCTCGCCGGGGTCCCCACCGGCCTCACGGCCCGGCGCGATCCACGGGGCCGGCTGGAGATCGTGGTGGAGACACCCGCCCCGGTGGCGGACGCCCGTCCGGGCACGGGCCAGGACCGGCTCCTCGACCTCGTCACGGAGATCTGGGCACAGGCACTCGAGGTGCCCGGACTCGCCCCGGACGACGACTTCTTCACCTGCGGCGGGCACTCGCTGCTGGCCACCGCGCTGGTGAGCGAGATGCAGGAGACACTCGGCGTCAGGGTACGGGTCCGCGCGCTGTTCGAGAATCCGACCCCGGCAGAGCTGACCGCCCACCTGCGGGAGACCGAACCCGAACTGGACGGCATGCTCGAACTCCTCGCCGCGCTGCCGGACACCACGCCGGAGAAGAGCGCCGACGCGCCGGAGCAGCACGACGCGCACCCCGCCACCGCGCAGCCGGCGGGAGAAACCGCGCAGACCGTGGACACACCTCTGCTGTCCGGCCAGCGTCAGCTGTGGCTCGCCCAGCAGGCCGACCCGGACGCGCTCACCCACACCATCCCGCTCATCCTGGACCTGGCCGGACCGCTGAACCCGGGGGCGTTCGCCGCGGCGCTGAACGACGTGGTCGCGCACCAGCCGGGCCTGCGCGCCACGTTCGTCGAGGTCGACGGCCTGCCGGTGCAGCGGATCAGTCCCCACACCCCGGTCGACGTCCCCGTGATCGACCTGACCGACCACGACGACGCCGCCCGCGAAGCCGAACTGCGGCGCCTGGAACAGGAGATCGCCTACACCGGATTCGACCTCACCCGCGGCCCGCTGCTGCGGGCCCGGATCATCCTGCTGGGGGCGGACCGCGGCCAGGTCCAGCTCCTGTTCCACCACCTGGTCACCGACGAGGTGTCCCAGACCCTGCTGATGCAGGAGCTGAGCACCGCCTACCGGGCCAGGACCGCCGGACGCGCTCCGGTCCTGCCGCCGCACGAGACCGACCTCGCCACCCTGGCCAAGGACGAGCAGGACTCCCTCGCCGGCGCGGAGGGCGAACGCCTGCGGCGGTTCTGGGTCCGTGAGCTGACCGGAGCGGCCCCGCTGCGCCTGCCCACCGACCGCCCGCGCGGCGACCGGGCCGGCTTCCGCGGCGAGTTCCTGGAACGACCGGCCTCCGCCGACGCGGCCACCACTCTGCGTGAACTGGCCGGCGTCTGCCGCACGACCCCGTTCACCGTGTTCTGCGCCGCCGTCGCGATCGTGCTGAGACGGCTGAGCGGCCAGAGCGACATCGTCATCGGGATCCCCACCGCCAACCGCACGCAGCGGGGAGCCGACCGGCTGATCGGCTGCTTCCTCAACGTCGTCCCGGTCCGGCTCGACCTGTCGGGCAACCCCCGCTTCGACGAACTCGTCCAGCGGGTGAGCGAGGCCGTCCTGCGCTCCTACGAACACCAGCAGCTGCCCTTCGCGGAGATCGTCCAGGCGGTCCGGCCCCGGCGAGTGCCCGGTACCCACCCCATCTACCAGGTCACCTGCGAACTGCAGCTGGAGTCCTGGATGCCCGCCCGGTTCGCGGACCTGGACTGCGACTACCGCTTCGTCTCCCACGGCACGGCCCGCTACGACATGGCCTTCCACGGGCTGCTGCGCCCCTCCGGACTCTCGGCGATGGTGGAGCTCGACACCGACCTGTGGGACCGGGCGACCGGCTACCGGCGGATCGACCAGGTGCTGGAGCTGCTCGCCGTGGCGGCGCGCGGCCCGCGGACCCCGATCGACGACCTGCCCGTGACGGAGCGGGAGCCGCGGTCCCTCAGCCGGTGA	MRNRTERGFVLVPPVGADVSPDGSGGDVGETSAPALSDAAGVVPVPDDELVEVMPCGSSLQEFGARRRVRSGAGRRTPSTHTTIDDGVTCGQAEPYIQSASGIQSFRRVGTYDEITRPDRMGKWLEDNPPPPARPWASVCASRYRMSMRDYEDYMPLAVIQEHFWSSDGSATEQAPLTECVALAVRGPLDAAALRTAVGALLSRHEILRSAVRLHDGQPSQVVLPVPERLPLTITTLPSPDRDADARQARDRELSRFAATGIDPAAGCGIAFLLLRDSDPAGEDTLALAVHHIFADATAVRLLLSELAADYDAALAGAPSPVPEPELQYGDFTQWEHASLLPAVQEPDTAWWRETLRDAPTALDVRPDRPRRRVRRGAGRRVGLVLRGVDGPAVRNTARTLHASPYALCLAGWAAMITRSTGDTDLILGVLAANRTVPQLEPLVGQFANTVPLRLDLAGAPDLADAVSRCSAAVAAAVEHGRLPFNRIVRAAAAPRPTDRPPLIQHMFMPRVDAVGELTLGGQPVRTLDVERDRGRFDTVAEIDVTGDQVRLWLEYDSDLYTPDGIHALVDDYAGVLRQWLARPALRLPELELSAPEPAGLALDDREPADGKPAEELRVDLPGGGAVTFLLDRSPGPEYRPVLAGLRGARAEDLELRPGGSVHHPTDLLLAGVPTGLTARRDPRGRLEIVVETPAPVADARPGTGQDRLLDLVTEIWAQALEVPGLAPDDDFFTCGGHSLLATALVSEMQETLGVRVRVRALFENPTPAELTAHLRETEPELDGMLELLAALPDTTPEKSADAPEQHDAHPATAQPAGETAQTVDTPLLSGQRQLWLAQQADPDALTHTIPLILDLAGPLNPGAFAAALNDVVAHQPGLRATFVEVDGLPVQRISPHTPVDVPVIDLTDHDDAAREAELRRLEQEIAYTGFDLTRGPLLRARIILLGADRGQVQLLFHHLVTDEVSQTLLMQELSTAYRARTAGRAPVLPPHETDLATLAKDEQDSLAGAEGERLRRFWVRELTGAAPLRLPTDRPRGDRAGFRGEFLERPASADAATTLRELAGVCRTTPFTVFCAAVAIVLRRLSGQSDIVIGIPTANRTQRGADRLIGCFLNVVPVRLDLSGNPRFDELVQRVSEAVLRSYEHQQLPFAEIVQAVRPRRVPGTHPIYQVTCELQLESWMPARFADLDCDYRFVSHGTARYDMAFHGLLRPSGLSAMVELDTDLWDRATGYRRIDQVLELLAVAARGPRTPIDDLPVTEREPRSLSR	MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFGLDIGKMREHEIAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVATIASMLYTGGQALAADGKEFVLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEIARTLWIGAKSMFGAILILVFAWTIGSVIGDMKTGSYLSTMAQGNINPHWLPVILFLLSGLMAFSTGTSWGTFGIMLPIAGDMAGATDVALMLPMLSAVLAGAVFGDHCSPISDTTILSSTGARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFSFIAASITFVIVCAILSWLSKSKMASCQNA	343.90	gnl|BL_ORD_ID|1927|hsp_num:0	1969			747	849	tetracycline
BGC0000960.1|Azinomycin_13 # 20878 # 22185 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.730	BGC0000960.1|Azinomycin_13 	20878	22185	-	Loose	300	59.6918	tet(44)	27.16	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGTGGATCCACCGGACGGTGGGCCGGTCCGTCGGCCACCGCACTGCTGCGTTTCGCGACGGCCGGGTCGGTCGACGACGGCAAATCCACCCTCGTCGGCCGTCTTCTGTACGACTCCAAGTCGGTCCTCACCGACCAGTGGGAGGCCGTCGAGCGCGCCTCCCGCCACCGCGGCCAGGACGCCCCCGACCTGGCGCTGCTCACCGACGGCCTGCGCGCGGAGCGGGAGCAGGGCATCACCATCGACGTCGCCTACCGCTACTTCGCCACCGCCCGGCGCCGGTTCATCCTGGCGGACACCCCCGGGCACGTGCAGTACACGCGGAACATGGTGACGGGCGCGTCCACGGCCGAGCTGGCCCTCGTCCTCGTCGACGCCCGCCACGGCGTGGTCGAGCAGACCCGCAGGCACGCCACCATCGCCGCCCTGCTGCGCGTCCCGCACCTCGTCCTCGCCGTCAACAAGATGGACCTGGCGGGCTACGAGGCGCGGGTGTTCGCCCGGATCGCCGAGGAGTTCACCGCGTACGCGACGGAGCTGGGCGTCCCGGAGGTCACCGCGATCCCGATCTCCGCGCTCGTCGGCGACAACGTCGTGGAACCGTCGGCGAACATGGACTGGTACGGCGGTCCCACCGTCCTGGAGCACCTGGAGACGGTCCCGGTCAGCCACGACCTGACCGGCTGCCACGCCCGCCTCCCCGTCCAGTACGTGATCAGGCCGCGGACCGCCGAGCACCCGGACTACCGCGGCTACGCGGGTCAGATCGCCGCCGGTGCGTTCCGCGTCGGCCAGGAGGTCACGGTCCTGCCCTCCGGCGCCACCTCGCGCATCAGCGGTATCGACGTGCTGGGCGAAGCGGTCGGCGAGGCGCGGGCGCCGCAGTCGGTGACGCTCCTGCTGGAGGACGACATCGACGTCGCGCGCGGTGACCTCCTGGTGCCGTCAGGGGACGGCCCGGTCGCCCGCCGGGACGTCGAGGCGACGGTCTGCCACGTCGCGGACGCGCCGCTCGCGGTCGGGCAGCGGGTGCTCCTCAAACACACCACCCGTACCGTCAGAGCCATCGTCGCGGAGATCCGGTCCCGGCTCGTCCTGGACGGGATCGTCGCGCACCCGGAGCCCGGGCAGCTGGTCGCCAATGACATCGGCCGGGTCCGGATCCGTACCGCGGAGCCGCTCGCCGTGGACGCCTACGCCGACTCGCGGCGCACCGGCTCCTTCCTGCTGATCGACCCGGCCGACGGGACGACGCTCGCCGCGGGCATGGCGGGTCCCGCGTTCGGCGCGGCCGTCACCGGCTGA	MSGSTGRWAGPSATALLRFATAGSVDDGKSTLVGRLLYDSKSVLTDQWEAVERASRHRGQDAPDLALLTDGLRAEREQGITIDVAYRYFATARRRFILADTPGHVQYTRNMVTGASTAELALVLVDARHGVVEQTRRHATIAALLRVPHLVLAVNKMDLAGYEARVFARIAEEFTAYATELGVPEVTAIPISALVGDNVVEPSANMDWYGGPTVLEHLETVPVSHDLTGCHARLPVQYVIRPRTAEHPDYRGYAGQIAAGAFRVGQEVTVLPSGATSRISGIDVLGEAVGEARAPQSVTLLLEDDIDVARGDLLVPSGDGPVARRDVEATVCHVADAPLAVGQRVLLKHTTRTVRAIVAEIRSRLVLDGIVAHPEPGQLVANDIGRVRIRTAEPLAVDAYADSRRTGSFLLIDPADGTTLAAGMAGPAFGAAVTG	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	67.97	gnl|BL_ORD_ID|1197|hsp_num:0	1171			3	447	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000960.1|Azinomycin_14 # 22185 # 22997 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.717	BGC0000960.1|Azinomycin_14 	22185	22997	-	Loose	350	25.7942	vanZ gene in vanF cluster	36.0	3002963	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanZ; glycopeptide resistance gene cluster	GTGATCCTGTTCTCCGGCGGCAAGGACTCGATCGTCATGCTGCACCTGGCGCTCAAGGCGTTCGCGCCCGCGCCGGTCCCCTTCTCGCTGCTGCACGTCGACACCGGGCACAACTTCCCCGAGGTCCTCGCCTACCGCGACCGCGCGGTGGCCCGCCACGGACTGCGGCTGCACGTCGCCTCCGTGCAGGACTACATCGACCGCGGGGTGCTCAAGGAGCGCCCGGACGGCACCCGCAACCCGCTGCAGACCGTGCCGCTCACGGAGAAGATCCACAGCGAGCGGTTCGACGCGGTCCTCGGCGGCGGGCGCCGCGACGAGGAGAAGGCCCGCGCCAAGGAGCGCGTGTTCAGTCTCCGCGACGAGTTCTCGCAGTGGGACCCGCGCCGCCAGCGCCCGGAACTGTGGCAGCTGTACAACGGGCGGCACGGCCCCGGCGAGCACGTCCGCGTCTTCCCGCTGTCCAACTGGACCGAGCTGGACGTGTGGCAGTACATCGCCCGCGAGGACATCGAACTCCCCGGGATCTACTACGCCCACGAGCGCCCGGTGTTCCGCCGCAACGGCATGTGGCTGACCGCCGGCGAGTGGGGCGGCCCCAAGGACGGCGAACGCGTCGAGACCCGGCTGGTCCGCTACCGCACGGTCGGCGACATGTCCTGCACCGGCGCCGTCGACTCCGACGCGGTGACGCTGGACCAGGTCGTCGCCGAGATCGCCACGTCCCGGCTCACCGAGCGGGGCGCCACCCGGGCCGACGACCGGCTGTCCGAGGCCGCGATGGAGGACCGCAAGCGTGAGGGGTACTTCTGA	MILFSGGKDSIVMLHLALKAFAPAPVPFSLLHVDTGHNFPEVLAYRDRAVARHGLRLHVASVQDYIDRGVLKERPDGTRNPLQTVPLTEKIHSERFDAVLGGGRRDEEKARAKERVFSLRDEFSQWDPRRQRPELWQLYNGRHGPGEHVRVFPLSNWTELDVWQYIAREDIELPGIYYAHERPVFRRNGMWLTAGEWGGPKDGERVETRLVRYRTVGDMSCTGAVDSDAVTLDQVVAEIATSRLTERGATRADDRLSEAAMEDRKREGYF	MLTPLTVLYTYFCTIIFCIVFQIGFFFKALKNISIRHFLWVYVFLFYLALVYMMTGIGNVWVVGRYETLIRVSEINLLPFSSEGVTTYILNIILFMPLGFLLPTIWPQFRTIKNTACTGFFFSLAIELTQLLNHRITDIDDLLMNTLGAIIGYLLYRAFKMIYTRDEKKLDNKSSLVIKYEAIFYIVCSFIGMILLYYPFLLRKII	131.07	gnl|BL_ORD_ID|4684|hsp_num:0	1669			321	396	vancomycin
BGC0000960.1|Azinomycin_15 # 22994 # 23104 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.676	BGC0000960.1|Azinomycin_15 	22994	23104	-	Loose	550	21.1718	NmcR	54.55	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGACGGCGACGACACCGCTCCCGCGCTACGGGATCAGCCATCTGGACGCGCTGGAGTCCGAGGCCGTGCACATCTTCCGGGAGTGGCGGGCGAGTTCGAGAAGCCGGTGA	MTATTPLPRYGISHLDALESEAVHIFREWRASSRSR	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	12.20	gnl|BL_ORD_ID|1905|hsp_num:0	2072			816	849	cefoxitin; cefazolin; ampicillin
BGC0000960.1|Azinomycin_16 # 23101 # 23661 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.708	BGC0000960.1|Azinomycin_16 	23101	23661	-	Loose	1000	25.7942	msbA	35.42	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGTGATCGGGCCTGAATCATGTGACTGCGGCGTGACCGTCCTGCTGACGGGGCTGCCGAGTGCGGGCAAGACGACGGTCGCGTTCCTGGTCGCCGGGCGACTGCGCGACGCGGGACACCGAGTGGAGGTCCTGGACGGTGACGTCATGCGGAAGACACTGTCGGCAGGGCTCGGATTCGGCCGGGCGGACCGGCACGAGAACCTGCAGCGGATCGGGGTGATGGCCGAGGTCCTCGCCCGCAACGGCGTGATCGTCCTCGTGCCGGTGGTCGCGCCGTACGCCGACAGCCGCGACGCCGTCCGGCAGCGGCACACCGCGAGCGGGACCGCATTCCTGGAAGTCCATGTGGCCACGCCCGTGGAGGTCTGTGCGCAACGGGACGTCAAGGGCCTGTACGCCCGGCAGCGGGCCGGCGAGCTGACCGGTCTCACCGGGGTCGACGATCCCTACCAGGCGCCCGAGAAGCCCGACCTCGTCATCCCGACGGTCCGGCAGTCGGCCGACGCGTCGGCCTCCCTGCTCATGGACCTGCTCGTGCGGAAGCGGTTCGTGGCATGA	MVIGPESCDCGVTVLLTGLPSAGKTTVAFLVAGRLRDAGHRVEVLDGDVMRKTLSAGLGFGRADRHENLQRIGVMAEVLARNGVIVLVPVVAPYADSRDAVRQRHTASGTAFLEVHVATPVEVCAQRDVKGLYARQRAGELTGLTGVDDPYQAPEKPDLVIPTVRQSADASASLLMDLLVRKRFVA	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	31.96	gnl|BL_ORD_ID|2185|hsp_num:0	2423			1104	1245	metronidazole
BGC0000960.1|Azinomycin_17 # 23726 # 24127 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0000960.1|Azinomycin_17 	23726	24127	+	Loose	600	28.4906	MexC	30.23	3000800	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGACAACTGACAAGACCGACAGCCGACTTGGGCCCTACGTCGAGCACCTGGGCCTGCAGTTCGAGCGGATCGACCCGGACCGGGCGGTGGCGTACTGGTCGGTGCGCGCCGACCTGCTGCAGCCTCACGGGATACTGCACGGCGGGGTGCACTGCGCTGTGGTCGAGTCCGTCGCCAGCGCGGCAGCGGACCGCTGGCTGGGCGACCGGGGGACCGTGGTCGGGGTCAGCAACAGCACGGACTTCTTCGCTCCCGCGACCGTGGCCGACGGCCGTCTCACGTCGACGGCCCTGCCGGTCCACCGCGGCGCCACCCAACAGGTCTGGTCGGTGGAGACGGTGGACGCGGCGGGCCGGCTCGTCGCCCGTGGACAGGTCCGGCTGCACAACCTCCGCTGA	MTTTDKTDSRLGPYVEHLGLQFERIDPDRAVAYWSVRADLLQPHGILHGGVHCAVVESVASAAADRWLGDRGTVVGVSNSTDFFAPATVADGRLTSTALPVHRGATQQVWSVETVDAAGRLVARGQVRLHNLR	MADLRAIGRIGALAMAIALAGCGPAEERQEAAEMVLPVEVLTVQAEPLALSSELPGRIEPVRVAEVRARVAGIVVRKRFEEGADVKAGDLLFQIDPAPLKAAVSRAEGELARNRAVLFEAQARVRRYEPLVKIQAVSQQDFDTATADLRSAEAATRSAQADLETARLNLGYASVTAPISGRIGRALVTEGALVGQGEATLMARIQQLDPIYADFTQTAAEALRLRDALKKGTLAAGDSQALTLRVEGTPYERQGALQFADVAVDRGTGQIALRGKFANPDGVLLPGMYVRVRTPQGIDNQAILVPQRAVHRSSDGSAQVMVVGADERAESRSVGTGVMQGSRWQITEGLEPGDRVIVGGLAAVQPGVKIVPKPDGAQAQAQSPAPQQ	34.37	gnl|BL_ORD_ID|744|hsp_num:0	805			744	873	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000960.1|Azinomycin_19 # 25755 # 26018 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.682	BGC0000960.1|Azinomycin_19 	25755	26018	-	Loose	100	25.7942	FosI	73.33	3007370	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGGCGAGCCCTGGGCTGGTCCACGACGAAGACCGCATCCGTTACGTGCAGAGCGTGTTCCGACGCGTACTCCGTCTGGAACAGGACGCGGCCCCCGACGACGACTTCTTCGTGCTCGGCGGAACCTCGCTGGCCGCCATGGAAGTGATCGACCTGATCGAGCGGGAACGGGGGCTGCGCATCCCCGTACGGAACTTCTACCGCTCCACCGTGGTGCGCGCGCTGGCCCTCGAGCTCGACCCGTCCCGCAGGGAGGCCCCATGA	MASPGLVHDEDRIRYVQSVFRRVLRLEQDAAPDDDFFVLGGTSLAAMEVIDLIERERGLRIPVRNFYRSTVVRALALELDPSRREAP	MKGISHITFIVRDLNRMAALLCEGLGAREVYDSSNQNFSLSREKFFVLGSTWLAAMEGEPPAERSYQHVAFAVSETDLPAYQARLEALGVEIRPPRSRVDGEGLSLYFYDFDNHLFELHSGTLEQRLVRYQAGR	64.93	gnl|BL_ORD_ID|4905|hsp_num:0	5898			126	171	fosfomycin
BGC0000960.1|Azinomycin_20 # 26021 # 27043 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.751	BGC0000960.1|Azinomycin_20 	26021	27043	-	Loose	800	26.1794	MuxA	32.0	3004073	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGACGGCGCGCCCCGCCGAGCAGACCCCGCAGCCGGTCCTCGGCCCGGATCCCCGGGCCGCGTACCGCGAGGCGCTGCTGGAACTGGCCGCCGCCGACAGCCGCGTGGTCTGTCTCGACTCCGACACCGGCGGCCTGGAGAACACCTTCGGCGAGCGCTTCCCGGACCGGTACGTCAATGTCGGGATCGCGGAGGCGAACCTGATGACGGTGGCCGCCGGACTCGCCCGCCGCGGATTCCTTCCCTACGTGCACACGATGGCCACCTTCGCCACGATGCGCGCGGGCGAGTTCCTCAAGCTGGACGTCGTGGGAAACCGGCTACCCGTACGGGTGGTGGCCACCCACGGCGGTCTCTCCGCCGCCCACTTCGGCACCAGCCACTTCGCGCTGGAGGACCTCGCGGTGACCCGCGCCCTGTCCGACCTGACCGTCGTCGTACCCGGTGACGCACGCCAGATCGGCCCTGCCATGCGCCAGTTGCACGAGGTGCCCGGTCCCGCCTACCTGCGGCTGGGCCGCTCGGCCACCCCCGTGCCGCCGGGGCCTGCCCCCGCCTTCCGGCTGGGCCGCGCCCGGGTCCTGCGCGAGGGCGCCGACGTCACGCTGGTGGCCGCGGGACCGCTGCCCCTGCTCCTCTCGCTGGAGGCCGCGGCAGAACTGGCTGCCGACGGCACCGAGGCGCAGGTCCTGGACCTGCACACCCTGCACCCGTTGGACCACGAGGGCCTGTTGGCGGCGTGCCGGGGCCGCGCCGGAGTGGTGACGGTGGAGGAGCACCGGCCGCAAGGCGGGCTGGGCGACGCGGTCACCGAGGTGGTCGCCGCCGAACTGGCTCTCCCGGTGCGCCGCGTGGCCGTACGAGGCCGTCCCGGCGTGCGCGTCGCCGGCCAGCGGGCCGCGCTGGAGCAGCTCGGCGTGAGCACCGGCGCGGTGGCGGACGCGGCCCGGCACCTGCACGCAGCACGAGCCGAATCACCGGCGCAGCACACTGCCGCCGGCCCAACCATGAGGGGATGA	MTTARPAEQTPQPVLGPDPRAAYREALLELAAADSRVVCLDSDTGGLENTFGERFPDRYVNVGIAEANLMTVAAGLARRGFLPYVHTMATFATMRAGEFLKLDVVGNRLPVRVVATHGGLSAAHFGTSHFALEDLAVTRALSDLTVVVPGDARQIGPAMRQLHEVPGPAYLRLGRSATPVPPGPAPAFRLGRARVLREGADVTLVAAGPLPLLLSLEAAAELAADGTEAQVLDLHTLHPLDHEGLLAACRGRAGVVTVEEHRPQGGLGDAVTEVVAAELALPVRRVAVRGRPGVRVAGQRAALEQLGVSTGAVADAARHLHAARAESPAQHTAAGPTMRG	MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE	79.81	gnl|BL_ORD_ID|2242|hsp_num:0	2717			852	1002	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000960.1|Azinomycin_22 # 27972 # 29294 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.745	BGC0000960.1|Azinomycin_22 	27972	29294	-	Loose	2090	26.9498	mdsB	36.54	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGAGCTCGCCCACGCCACGACCCGCCTGGCCCTGCTCGGCGGAGACCGGGCCGTACCGAAGGACAGCGTGGGCGGCACCTGGCCGCTGGTCACCACCGCCGACGAACAGGCCGTGCTGCGGGTGTTGCGCGAGGGCCCGCTGAACGCCGCCTCCCCCGGAGAACGCGAGGTCGGCGGCCTGGAACGGGCCTGGGCGCAGGCCACCGGGACCCGGCACTGTGTCGCTGTCGCCTCCGGCACCGCCGCACTGCATCTGGCCCTGCGCGGCTGCGGGATCGGTCCGGGCGACGAGGTGATCGTCCCGGCACTGACCATGAACGCGACCGCCCACGCGGTGTGCGCGGCAGGCGCCACACCCGTGTTCGCCGACGTGGATCCCGACACGTACACACTCGACCCGCGGTCCGCCGCAGCGGTCTGCGGACCGCGAACCGCCGCGCTCCTGCCGGTACATCTGCACGGACTGCCGGCCGACATGCGGGCGCTGGACGAACTGGCCGGCCGACGGGGCGTCCCCGTCGTGGAGGACGCGGCCCAGGCACACGGCGCGCAGCTCGACGGGCGCCGGGTCGGCGCCCTCGGCAAGGCGGGCTGCTTCAGCCTGCATCCCCACAAGAACCTGCCGAGCTGTGGTGAGGGGGGACTGATCACCACCGACGACGACAGCCTGCACGAACAGCTGGTACGGCTGCGCAACTTCGGCGAGCTGGAACCCACCGGGGCTCGCAGCTACATCGCCCACCGGGCCGCCCTCAACGCCCGGATCACACCGATGGCAGCCGCGTTCACCCGCTCCCAGCTGGCCCGCTTCGACGACTACGCCCGCCGCCGCGAGCCGGGAATCCGCCGGTTCCTGAACCGGCTGGCTCAGCTGCCCGGACTGCGGGTGCCACAGGTCCCGGCCGGACGCACCCACGCCTGGCACATCCTGCGGCTGATGCCGGACCCGGAGGCGTTCGGCCTCGGGCCCGAGCACCGCTGCGCCCTGCGCGCCGCCCTGCACCGGATCCTGCGGGCCGAGGGGGTGCCCGTCTCCCGGTACCAGGTCGCTCCGCTCGCGGCGCAGCCCGCGTTCCGTCCCCCGGGTGCGTCCCCGGCGGACGCCGCGGACCAGGTGGACGCCCTCCTCCCGGTGACCGTCGCCGTCGTCGACGGATCGCTGTGCCTGCAGCGCCGGCACCTCGATCCGGCCGCCGGGCCCCTGCTGCAGTCGTACGCCGACGCGTTCGAGAAGGTCTGGCAGAACCTCGAACTCGTCCGCCGGATGGCCACCTCCCGCTCCGCTCCCGGCTGGCGGGAGGCGCTGCGCCAGGGGTGA	MPELAHATTRLALLGGDRAVPKDSVGGTWPLVTTADEQAVLRVLREGPLNAASPGEREVGGLERAWAQATGTRHCVAVASGTAALHLALRGCGIGPGDEVIVPALTMNATAHAVCAAGATPVFADVDPDTYTLDPRSAAAVCGPRTAALLPVHLHGLPADMRALDELAGRRGVPVVEDAAQAHGAQLDGRRVGALGKAGCFSLHPHKNLPSCGEGGLITTDDDSLHEQLVRLRNFGELEPTGARSYIAHRAALNARITPMAAAFTRSQLARFDDYARRREPGIRRFLNRLAQLPGLRVPQVPAGRTHAWHILRLMPDPEAFGLGPEHRCALRAALHRILRAEGVPVSRYQVAPLAAQPAFRPPGASPADAADQVDALLPVTVAVVDGSLCLQRRHLDPAAGPLLQSYADAFEKVWQNLELVRRMATSRSAPGWREALRQG	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	41.71	gnl|BL_ORD_ID|1269|hsp_num:0	1385			93	249	chloramphenicol
BGC0000960.1|Azinomycin_23 # 29496 # 29675 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.694	BGC0000960.1|Azinomycin_23 	29496	29675	+	Loose	850	21.9422	OprJ	72.73	3000802	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTACGGCGCTGAGCGTGCCGTGTCCCGAGTGCGCCGGGACGCTGGAGGTACGCCCTGATGTGCTCGCCGCCGAGATCGTGGTCTGCGGACAGTGTTCGAGCGAGCTCGAGGTCGTGGCGACCGGGCCCGTGGTGCTGGCCCTCGCTCCGGAGGTCGAAGAGGACTGGGGCGAGTAG	MTTALSVPCPECAGTLEVRPDVLAAEIVVCGQCSSELEVVATGPVVLALAPEVEEDWGE	MRKPAFGVSALLIALTLGACSMAPTYERPAAPVADSWSGAAAQRQGAAIDTLDWKSFIVDAELRRLVDMALDNIRSLRQTLLDIEAARAQYRIQRADRVPGLNAAATGNRQRQPADLSAGNRSEVASSYQVGLALPEYELDLFGRVKSLTDAALQQYLASEEAARAARIALVAEVSQAYLSYDGALRRLALTRQTLVSREYSFALIDQRRAAGAATALDYQEALGLVEQARAEQERNLRQKQQAFNALVLLLGSDDAAQAIPRSPGQRPKLLQDIAPGTPSELIERRPDILAAEHRLRARNADIGAARAAFFPRISLTGSFGTSSAEMSGLFDGGSRSCSFLPTLTLPIFDGGRNRANLSLAEARKDSAVAAYEGTIQTAFREVADALAASDTLRREEKALRALANSSNEALKLAKARYESGVDNHLRYLDAQRSSFLNEIAFIDGSTQRQIALVDLFRALGGGWDEGRSLVVHRGGRS	12.32	gnl|BL_ORD_ID|745|hsp_num:0	704			849	882	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000960.1|Azinomycin_25 # 30737 # 31615 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=12bp;gc_cont=0.745	BGC0000960.1|Azinomycin_25 	30737	31615	+	Loose	500	32.3426	CARB-11	24.49	3005559	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	ATGGCGCAGGATCCGAGGGGGCACGAGCCGAACCCGCTGATCGGCGGGTTCGCGCACGACGGGCCGATCGTGGTCAAGATCGGCGGCGGGAGCGACCCGGAGCCCGTACTGGACGAGGTGGCCGAACTGGCGCTCGCCGGCCGGCCGACGGTACTCGTCCACGGCGGCGGAGCAGTCGCCGACCTGCTGTCGGAACAACTCGGCGTGGAGCGGCGGGTGATCAGGTCCCCGGACGGCACGCACAGCCGTCGCACGGACGCGGCCATGCTCGATGTCATCACCCTCGCCCTGCTCGGGCGGGTGAAACCACGTCTGATCAGCGGATTACGGGCACGCGGCGCACGGTCGGTGGGCCTGAGCGGCGCGGACGGCGCCCTGCTGACCGCCACCCGCAAACCGGCCCTGCGCTCCGTGCAGGACGGCCGGACCGTACTGATCCGGGACGACCGGTCCGGCCGCATCGAGCGCGTCGACCCCGCGCCGGTCCGCGCGGTGCTGGACCGGGGGCACGTCCCCGTGGTCTCCCCGCCGGCCAGCGACGCCGCGGGCAACCTGCTCAACGTGGACGCCGACGAGGCGGCGGCCCGGCTGGCGACCGCCCTGGACGCGTCGGCCCTGGTCCTGCTCACCGATGTGGGTGGCGTCCTGGCCGACCTCGGCGACCCCGCCACCCGGATCGCGCGGGTGGGCCCGCACCACCTGGAAGGCGACGTCGTCCGAGGACGGATGCGGCACAAGGTACGCGCCGGGCTGCGGGCCAGCAGGACCGTGCGGCAGGTGGCCATCGGCGCCGCGCATCTGCACCGGCCGATCCACCAGGCCCTCTCCGGTGCCGGCAGCCGGCTGTGCGACGAAGGGGAGAGGCCCGAAGATGGCTGA	MAQDPRGHEPNPLIGGFAHDGPIVVKIGGGSDPEPVLDEVAELALAGRPTVLVHGGGAVADLLSEQLGVERRVIRSPDGTHSRRTDAAMLDVITLALLGRVKPRLISGLRARGARSVGLSGADGALLTATRKPALRSVQDGRTVLIRDDRSGRIERVDPAPVRAVLDRGHVPVVSPPASDAAGNLLNVDADEAAARLATALDASALVLLTDVGGVLADLGDPATRIARVGPHHLEGDVVRGRMRHKVRAGLRASRTVRQVAIGAAHLHRPIHQALSGAGSRLCDEGERPEDG	MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNSNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR	101.39	gnl|BL_ORD_ID|3340|hsp_num:0	4409			222	501	
BGC0000960.1|Azinomycin_28 # 33636 # 38261 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=9bp;gc_cont=0.736	BGC0000960.1|Azinomycin_28 	33636	38261	+	Loose	1000	127.102	almE	25.09	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGATCTGCCCACCGAGCAGCCACGGTCCCTGCCGGACACGCCGGTGGCCGCCGCGGTGCCGCCCGATCTCGCCGCCCTGCGCTCGCGGCTGGCCGAACTGAGCCCGGAAAAACGCCGGTTGGTGGAGCGACTGCTGGCCCGTCAGGGCGCCGGCCTCGGCATCACCCGTCGCGCCGGCGGTGCGCCCGAGGCCCCCTGCTCCTTCGAGCAAGAGCGGCTGTGGTTCATGTACGAGCTGCTGACCCGGCGCGAGATCTTTCACGTCCCGGTCGCCCTGCGCCTCGAAGGCGAACTGGACCCCGACGCGCTGGAGCGGGCACTGCGGCAGCTCGGCCGACGGCACGAGGCACTGCGCACCGTGTTCCGGCAGCGCGACGGCCGCCCCTACCAGGTGGTACGGGAACAGCTCGATCTCCCGCTGGAGCGGGTCGACTGCCGCACCGCCGCCGATCCCGCCCTCGCCGCCCGGCAGCAGGCCTCCGCACTGGTCACCGAGGACTTCGACCTCGAAGAAGGACCCCTGGTGCGCTGCACGCTGTACCGGACGGGGGAACACGAACACCTGCTGGCCGTGGTGCAGCACCACATCGTCTCCGACAACTGGTCGCTGGGCATCCTGCTCGACGACCTCGGCAAGCTGTACGCCCGCGAGCTGGGGGCACCGGGGGAGCTGCCCCCGCTCGACCTGCACTACCCCGACTTCGCCGCATGGCAGCGGGCCACGGTCGACAGCACGACGATGCGGCGCACCCTCGATCACTGGCGCGACCGCCTGGACGGCGCCCCGGACAGTCTCGACCTGCCCACCGACCGTCCCCGGCCCGCGGTCCGCGGCAGCCAGGGGAAGTTCCACCACGTACGGTTCGACGCCGACCTGGTCGCCGGGCTGCGCGAAGCGGCCCGGCAGCACGACACCACCCTCCTGGGCGCGTTCCTCGCAGGGTACATAGCCCTGCTCTCCCGCCTCGTGCGGTCGGACTCGCTGGTGGTCGGTGTACCGGTGGCCGGGCGGCCGCGCGCGGAGATGCAGCAGATGATCGGGTACTTCCTGAACTGGCTGCCGATCCACGTCCAGGTCGGTGACCGGCCGGACCTGCACACCCTGATACGCCGCACCGGAACCGCCCTGAGCGAGGCGATGACCCATCAGGACGTGCCGTTCGACATGCTGGTGCGCGAGCTGCGGCCCTCGCGGCGCCCCGGGGAGACACCGATCTTCCAGACCTCCTTCTCGCTGCGTGACGGCGCCCCCACCCCGCCGGCCATGCCGGGCATCGACGTCACCTTCGCCGAACTCGACGGCGGAGCCACCCATTACGACCTGATGGCCGAACTGTGGTGCGAGGGCGACGAGGTCGTGGGCTACGTGCCCTACGACGACGAACTGCTGGACGCGCAGACGGTGGCCCGCTGGGCCGGCTGGCTCAAGACGCTGCTGCGCGCCGGGCTGGCCGCACCGGACACCCCGGTGGCGGACCTGGAGATGCTCGCTCCCGGCGAGTCCGTGGTGATCCCGGCCCGCGCGCCGGTGACGGCCGAGGGGGGCGTCGCCCGGCCGGCCCGGACCCTGCACGGGGTGTTCGCCGCGCAGGCGGCTCGGCGGCCCGACGCCCCCGCCGTCTCCGACGAGCGGGACCGGCTCACCTACGCGGAACTGTCCGCACGAGCCGACCGGATCGCCGCCGCCCTGCAAGAGCGGGGTGAGGGACCCGGCAGCATCGTCGGCCTCGTCCTCGACCGCACCGTGGACCTGCCCGCCGCCGTTCTCGGCGTGCTTCGCGCGGGTGCCGCCTACCTGCCCGTCGACCCGGAGAATCCCGCCGGACGCACCGCTGACCAGTTCACCGAGTGCCGGGTCCGGACCGTGCTGACCACCCCGGCCACCGCGTCGGCACCCGCGTTGGAGGAACTGGACGACGGACCGCGCATCCTCGTGGTGGACTGGCAGGACCCCGGATGGCGGGAGCAGACCCCCGGCCCGGCTGCCGTGGACGTACCCGCGGACGCGCCCGCCTACGTCATCTACACCTCGGGATCCACCGGCCGCCCCAAGGGCGTGCTCGTCACGCACCGCAACGTGCTCCGGCTGTTCACCGCCTGCGACGAGCATCTGAGGGTGGGGCCGGACGACGTATGGACCCTGTTCCACTCCTACGCCTTCGACTTCTCCGTCTGGGAGATCTGGGGTGCGCTGCTGCACGGCGGCAGGCTGGTGGTCGTCCCGCAGTGGGCGACCCGCGCCCCCGACGTCTTCGCCGAACTCGTACGGGACGAGCGGGTCACCGTGCTGAGCCAGACCCCGTCCGCGTTCGGCCAGGTGAGCGAGACCCTGCTGAAGCACCCCGACCCGGCGGCGCTGCGGTACGTGGTGTTCGGCGGCGAGGCACTCGATCCCACCGCGCTGCGTCCCTGGACGCGTGTGTACGGCGACCGGCGGCCGGAACTGATCAACATGTACGGGATCACCGAGACCACCGTGCACGTCACCGCGCGGCCGCTGCGCGAGAAGGACCTCGCCGGGACGGCGTCCCCGATCGGACCTCCGCTCGCCGACCTGTCCCTGTACCTGCTGGACGATTCCCTGCGTCCGGTCGGCACCGGTGTACCCGGGGAGATCTTCGTCGGAGGGGACGGGGTGAGCCTGGGCTACGTCGCCAACCCGGGGCTGACCGCGGAGCGCATGCTCCCCGACCCGTTCGCCGGACGTCCCGGCGCCCGTATGTACCGCAGCGGCGACCTGGCGGTCCGCCGCGGCGACGGAGAGCTGGTCTGTCTGGGCCGCGCCGACGACCAGGTGAAGATCCGCGGGCACCGGATCGAGCCGGGTGAGGTCCGGGCGGCGCTGGACGCCCTGGCCGTCGTCGCCCGTGCCGCCGTGGTGGTGGAACGCGACCGGGTGGGCGCCGCCGTCCTGGCGGCCTACGTCGTACCGGCCGAGGGGAACGCCGGCGTCAGCGGCACCGGGATTCGCCGGACCCTGCTGCGCTCCCTGCCGGAATGGATGGTGCCCGCCTCGGTCACCGTCCTCGACGAGCTGCCCCTGACCCGGAACGGCAAGCTGGACCGCCGGGCCCTGACCGACCGCAAGGAGCACGCGGCGCCGGCCGGACCGCGCGGCGAGGCGCCCCGCAGCGACACCGCGCGGCAACTTGCCGAGATCTGGCAGGAGCTGCTCGGCGTCCCCGCGGTGGGCGGCGAGGACAGCTTCTTCGAACTCGGCGGCCACTCCCTGATGGTGATGCACCTCGTCGCCCGGATACGCACGGCCTTCGGCGTCGAGATGCCGGTGGAGACCCTCTTCCGCCGCCCTCAACTGCAGCCGCTGGCCGACGAGGTGGACGCGGCACGTACCGCGGCGCAGAGGGCCGCGGCGCCGGAGCCGGGACAGGACGCGGCGGCCGAACTCGCCGACGTGCGCGCCGACCTGGCCGCCCGGGCCGCCGGGATCCCCCGCCCGGGGGCCCGGGCGGACGCGGACCGCGACACAGTCCTGCTCACCGGGGCCACGGGCTTCGTCGGCCGGTTCGTGCTCGCCGAACTCCTTGCCGCGGGGGCCCGGGTGATCTGCCTGCTCCGCGGCGGGACCGCCCGCCGGGAGGAGCTGGTGGCGGGGATGGCGGACCTCGGGCTGTGGCACGAGGAGCACGCCGCACGGCTGGAACTGGTCGACGGCGACATCGCCGAACCCGGGCTCGGCCTCGCCGGACCGGACCGCGACCGCCTGGCCGACCGGGCGGGCCGCATCATCCACGCCGCGGCCTGGGTGAACCACGTCTACCCGTACGAGCGGCTGGCCGCGGCGAACACGCACTGCATGGCAGGTCTGCTGGAACTCGCGGCCCGCGGCCGCCGCTCGGCTCTCACTGTGGTGTCCACCAGCTCGGTGGCCGACTCCGCCGCGTACCCGCCCGGCTCGACCGTGCCGCCGGGCCCGCTGAAGGCACTGCCGTCCGCCGCGAACGGATACGTGCGTTCCAAGGCGGTGGCCGAGCAGTACCTCCACCTGGCAGCCGAACTGGACGTACCCGCCGCGGTGATCAGGATTCCCAGCGTCTTCGGCGATCAGCGGCGGTACCAGATCAACCCCGCAGACGCCGTGTGGAGTTGGTGCCGGGCGATGATCGAGACCAGCGGCTTCCCCGAGAGCTTCGCGCAGCCGGGCAACGAACTGTTCCAGGCGCTGCCCGCCGACGCCGTGGCCCGGGCGGTGCTGCTGGCCGACCGCGATCACACCGAACCGGGCACCCGCTACCTGGACGCCGTCCCGGCCGCCGTCGGCACGACAGAGGACCTGCTGGCCGCTCTGCGCGCCGCCGGTCATGCACTGAGCCCCTGCCCGGACCACGCGTGGTACACCGCCGTGGGCGAGCTGGACCCCGGCCGGGTCTGGGTGGCGGGCATCGCAGGGCAGGCCGCCGCCCGGCTGGCCGCGGATCCGTCCGCCACGGCCCCCCGCACCCTGCGCCGCTTCACCGCCCCCGTGGAGCCCGGTGAGCTGGACGAGCTGTTGCGCACCCGGGCCCTGTACTCCTCGGCCCAGCTGGCCGGGTACATCCGGACGCTCGACGCGTCCTTCCCGCCCGCCGGCAACGACCGGGAGAAAGCCCGGCCCGCGCGCGGCTGA	MDLPTEQPRSLPDTPVAAAVPPDLAALRSRLAELSPEKRRLVERLLARQGAGLGITRRAGGAPEAPCSFEQERLWFMYELLTRREIFHVPVALRLEGELDPDALERALRQLGRRHEALRTVFRQRDGRPYQVVREQLDLPLERVDCRTAADPALAARQQASALVTEDFDLEEGPLVRCTLYRTGEHEHLLAVVQHHIVSDNWSLGILLDDLGKLYARELGAPGELPPLDLHYPDFAAWQRATVDSTTMRRTLDHWRDRLDGAPDSLDLPTDRPRPAVRGSQGKFHHVRFDADLVAGLREAARQHDTTLLGAFLAGYIALLSRLVRSDSLVVGVPVAGRPRAEMQQMIGYFLNWLPIHVQVGDRPDLHTLIRRTGTALSEAMTHQDVPFDMLVRELRPSRRPGETPIFQTSFSLRDGAPTPPAMPGIDVTFAELDGGATHYDLMAELWCEGDEVVGYVPYDDELLDAQTVARWAGWLKTLLRAGLAAPDTPVADLEMLAPGESVVIPARAPVTAEGGVARPARTLHGVFAAQAARRPDAPAVSDERDRLTYAELSARADRIAAALQERGEGPGSIVGLVLDRTVDLPAAVLGVLRAGAAYLPVDPENPAGRTADQFTECRVRTVLTTPATASAPALEELDDGPRILVVDWQDPGWREQTPGPAAVDVPADAPAYVIYTSGSTGRPKGVLVTHRNVLRLFTACDEHLRVGPDDVWTLFHSYAFDFSVWEIWGALLHGGRLVVVPQWATRAPDVFAELVRDERVTVLSQTPSAFGQVSETLLKHPDPAALRYVVFGGEALDPTALRPWTRVYGDRRPELINMYGITETTVHVTARPLREKDLAGTASPIGPPLADLSLYLLDDSLRPVGTGVPGEIFVGGDGVSLGYVANPGLTAERMLPDPFAGRPGARMYRSGDLAVRRGDGELVCLGRADDQVKIRGHRIEPGEVRAALDALAVVARAAVVVERDRVGAAVLAAYVVPAEGNAGVSGTGIRRTLLRSLPEWMVPASVTVLDELPLTRNGKLDRRALTDRKEHAAPAGPRGEAPRSDTARQLAEIWQELLGVPAVGGEDSFFELGGHSLMVMHLVARIRTAFGVEMPVETLFRRPQLQPLADEVDAARTAAQRAAAPEPGQDAAAELADVRADLAARAAGIPRPGARADADRDTVLLTGATGFVGRFVLAELLAAGARVICLLRGGTARREELVAGMADLGLWHEEHAARLELVDGDIAEPGLGLAGPDRDRLADRAGRIIHAAAWVNHVYPYERLAAANTHCMAGLLELAARGRRSALTVVSTSSVADSAAYPPGSTVPPGPLKALPSAANGYVRSKAVAEQYLHLAAELDVPAAVIRIPSVFGDQRRYQINPADAVWSWCRAMIETSGFPESFAQPGNELFQALPADAVARAVLLADRDHTEPGTRYLDAVPAAVGTTEDLLAALRAAGHALSPCPDHAWYTAVGELDPGRVWVAGIAGQAAARLAADPSATAPRTLRRFTAPVEPGELDELLRTRALYSSAQLAGYIRTLDASFPPAGNDREKARPARG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	277.16	gnl|BL_ORD_ID|4935|hsp_num:0	5928			69	1638	colistin A; colistin B
BGC0000960.1|Azinomycin_30 # 38515 # 43854 # 1 # ID=1_30;partial=00;start_type=TTG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.734	BGC0000960.1|Azinomycin_30 	38515	43854	+	Loose	500	28.4906	APH(3')-IIc	38.33	3002646	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	TTGGCTGAGAATGTGCAGAACCCGCCCGTGGAGCCCCTCGCGGTGATCGGCATGAGCTGCCGGTTCGCCCCCGACCTCGACACCCCCGGCCGGCTCTGGGAGTTCCTGCGCGCCGGGGGCAGCGCGGTGGGCGAGATGCCCGACCGGCGCTGGGACCCGTACGTGACGGACAGCCGCACCCGCGACATCCTGCGCACGACCACCCGCAAGGGTTCGTTCATGCGGGACATCGAGGGCTTCGACGCCGAGTTCTTCCAGATCACGCCCCGCGAGGCCGAGTACATCGACCCGCAGCAGCGGATCATGCTCGAACTCGCCTGGGAAGCCCTGTGCGACGCCGGACTGCCGCCGACCTCGCTGGCCGGCACCGACGCGAGCGTCTACGTGGCGGCGAACTCCAACGACTACGGCCGCCGCCTGCTCGAAGACCTGGACCGCACGGGCGCCTGGGCCGTGAACGGCACCACCTTCTACGGCATCGCCAACCGCATCTCGTACTTCCTGGACGCGCACGGCCCCAGCATGGCCGTGGACACCGCCTGCGCCGGATCCCTGACCGCCCTGCACGTCGCGGGCCAGGCGCTGCACAGGGGCGAGACGAGCGTGGCCATCGTCGGCGGCATCAACATCATGGCCTCGCCGGCGCTGGTCGTGGCCCTGGACGCGGCCTCCGCGACCTCCCCGGACGGCCGCAGCAAGTCGTTCGACAAGGCGGCCGACGGCTACGGGCGCGGCGAGGGCGGCGGAGTCGTCGTGCTCAAGCGACTGTCCGACGCGGTGCGCGACGGTGACCCGGTGCACGGGCTCGTCCTGGCCAGCGGTGTCTTCCAGGACGGCCGCTCCGACGGCATGATGGCCCCCAACGGCAGTGCCCAGCAGCGCATGCTGGAAGAAATCTACCGGCGGTCCGGCATCGACCCCGGCACAGTGCAGTACGTCGAGGCGCACGGCACCGGCACCCAGCTCGGTGACGCCGCGGAGGCCCAGGCCATCGGCAATGTCTTCGGCCCCGGCAGGGACGGCGACAACCCCCTGCTGATCGGGACGCTGAAGCCGAACGTGGGCCACGTCGAGGCAGCCTCCGGCATCGCGGGCGTGATCAAGGTCCTGCTGGGGATGCGCCACGGCGAACTGCCGCCCAGCCCGCACGAGGAGCCCGATCCCGGGCTCGGGCTGGAGGCCAGGGGACTGCGTCTGGTCGCCGAGCCGACGCCGTGGCCGCGGGGCGAACACGGCATGCGCGCCGGTGTCTCCAGCTACGGCGTGGGCGGCTCGATCGCCCACGCCGTACTGCAGCAGGCCCCGCCGCGCCCGGACAGGACCGAGCGCCCGGCCGCCGCCGCCACGGGCCGCCCCCAGGTCTTCCCGCTGTCCGCCGCCTCCGAGCAGGGCGTACGAGGACTGGCCGGCTCGGTCGCCGCGTGGCTGCGGGCACACCCCGAGACCGCCCTGGACGATCTCGCCCACACCTTCACCGCCCGCCGCTCCCATCTCTCCCGCCGGGCCGCCGTCGTGGCCGGCACCACGGAGGAACTGCTCGGCGGACTGGACGCGTTGGCCGGCGGCGAGAAATCCCCCGCGGTGGCCCTGGCATCGGCGTCCGGGTTCGGTGACGGCGGCGCGGCCGGACCCGCCTGGGTGTTCTCCGGGCACGGCGCGCAGTGGTCCGGCATGGGCCGGGAACTGCTCACCACCGAGCCCGTGTTCGCCCAGGTCATCGACGAACTCGCCCCGGTCTTCTCCGAAGAGCTCGGATGGACCCCGCGCGAGGCGATCGAGGCGGGCGGCCCGTGGACCGTCGTCCGTACCCAGGCGATGACCTTCGCGATGCAGGTCGCCCTCGCCGAGGTGTGGTCGGACCTGGGCCTGCGTCCGGGCGCGATCATCGGGCACTCGGTCGGCGAGATCGCCGCCGCCGCGGTGGCCGGGAGCCTGGACCGCGCAGAGGCGGCACGCTTCGCCTGCCGCCGCGCCCGCGCCCTCGGAAAGATCGCCGGGCGTGGCGCGATGGCGATGGTGCCCATGGCGTTCGCCGACGTCGAACAGCGGGTCGCCGGCCGGGACGCAGTGGTCGCGGCGATCGCCGCCAGCCCTCTGTCGACCGTGGTGTCGGGTGACACGGCCGCGGTCGAGGCCCTGCTCGCGGACCTGGAGGCCGACGGCATCCAGGCTCGCCGGGTCAACACCGACGTCGCCTTCCACAGCCCGCACGTCCAGGAGATCCTCGACGAGGTCAGGCAGGCCGCCGCCGCACTGCGGGCCGGAACACCCCGGGTGACGCTGTACAGCACCGCCCTCGCGGACCCGCGCTCCGACGCTCCCCGTGAGGGCGAGTACTGGGCCACCAACCTGGCCGACCCGGTCCGCTTCCACCAGGCCGTACGGGCCGCGCTCGACGACGGCACCCGGGTCTTCCTGGAGGTCTCCTCGCACCCGGTGGTGGCCCACTCCATCACCGAGACCGCACTGGACGCCGGGGTCCCCGACGCCCACGTGGCGATCACCCTGCGCAGGGAACAGCCGGAGCAGCGCACCGTGCTGGCCAACCTGGCCCGGCTCCACAGCCTCGGCACTCCGGTCACCTGGTCCTACGACGGTGACCTCGTGGACGTCCCCGCGGTGCGCTGGCAGCACAAGCCGTACTGGATCTTCCCGGACACCGCACCGGAACAGGGCGCGGGCCTGGGCCACGACCCGCAGACCCACACGCTGATCGGCGCGCGCACCACCGTCGCCAGCGCTCCGGTCCAGCGCGTCTGGCAGACCGAACTGCACATGGAGAACCGTCCGTACGCGCAGTCGCACAAGGTCGTCGGCGTGGAGACGGTGCCCGCGTCCGTGGTGCTCAACTCGTTCATCACCGCCGCCACCAACGAGGGCGAACGGGCCTGCGGACTGCGCGACATCGTCTTCCGCATCCCGCTGGCCGCGCACCCGACACGGGTGGTCCAGGTGGTGCTGGAACAGGACAAGGTGCGCATCGCCAGCCGCATCAAGCGGGACCAGGAGAGCGGCGGCGTCCGCGACGACGAGTGGCTCACCCACACCACCGCGACCGTCGTGCACGAGCCGGAGGTCGGGGCGCGTCCGATGGAGGACCCGGACGTCATCCGGGCCCGCTGCCCGGTGTCCTGGACCTGGGCCAAGGTCGACGGGATCTTCCGGACCATGGGCGTGGACGGGTACACCTTCCCCTGGGTCGTGGAGGAGCTCCTGCGCGGTGAGGACGAGCAGTTCTCCACGATCACGGTGGACCACACGCCGAAGCTGCACCCGTCCAGCTGGACCGCGGTCGTCGACGCCGCGCTGACCGCCAGTGGTGTGCTGGTGATGGACGAGAACTCGAACGTCCTGCGCACCTGCTCGCACCTGGAGTCCCTGTCCTTCGTGGGCCCCCCGCCGCCCAGGATCCACGTACACACCGTGCGTGACCCGCGCACCCCGGACACCATCAGCATGACGGTGGCCGACGAGAGCGGCGCCGTGGTCTGCGAGGCCCGAGGGCTGCGCTACGTCAAGGTCCAGGACATCGGCTCCGGCGCGGTCGGCCCGCGCGACCTGGTGCACGAACTCGCCTGGGAGCCGGTGGAGGTCCCCGCGGACGCGCCGGTCCCGTCCCAGGCCCTGGTGGTGGGCGGCGCCGCCGGCGGCCCCGCCCTGGTCGAGGCGCTCACCGCACGCGGAGTGCGGGCACGGGCGGTACCGGACGCGACCGCGATCGGCGACGCCTCGCTCACCTGCGCCGACGTGGTCGTCGTGGCGCCCGAGGCGCTGCTGCCCGGGGAGGCACCCGAGCAGGCGGCGCGCCGGTGCGCGCAGCTGCTCGTCGACGCCGTGCAACAGGTGGCGGCCGTCCCGGACGAGCGGCGGCGGCCCAGGGTGTGGGCGCTCACCCGCGAGGTACGGGCGGGCGCGACGGAGGCCGCGCTCGCGCACGCCCCGCTGTGGGGCGCCGGACGCATCGTCGCCGGCGAGCGCCCCGACCTGTGGGGCGGCGTGATCGACGTCGCGGAGAACGCCGTACCCCAGCAGGTGGCCTCGCTCATCGGAGCTCTGCCGCACACCGAGGACGTACTGTCGCTCGACTCCGAAGGCGTCACCGCCGCCCGGCTGCGCCAGGTCGCGCGGCCCGCGGAGCGCGAACCGGTGGACTGCCGCCCCGACGGTACGTACCTGGTCACCGGCGGTCTGGGCGCGCTCGGCCTGGAGGCCGCGCGCCATCTGGTCGAGCAGGGCGCCAGGCGTCTGGTGCTCATCGGCCGGCGGGGTCTTCCCTCCCGGTCGCGGTGGGACCAGGTGGACGACCCCGCCGTGGCCGCGCAGATCGCCGAGGTCGTCGCCCTGGAGGCGGCGGGCGCCACGGTGCGTGTCCTCAGCCTGGACATCTCCGACGCCGAGGCGACGGCCCGTGCCCTGGACCCGGGCGCTCTGGACATGCCGCCGGTCCGGGGCATCGTGCACTGCGCCGGTGTGGTCTCCGACGCGCTGGTGGAGAAGACCGGTGCGGCGAACCTGGACACCACCATGGGCCCCAAGGCCGACGGCGCGATGGTCCTGCACCGGCTCTTCCCGGCCGGCACGCTGGACTTCTTCACGATGTTCTCCTCGTGCGGCCAGCTGGCACGGCTCACCGGCCAGGTCAGCTACGCCTCCGCGAACTCCTTCCTGGACGCGCTCGCCGCCTTGCGGCGTTCGCGGGGGGAGACGGGTACGACGAGCTTCGCGTGGGCGCAGTGGATCGGACGCGGCATGGGCGAGACCACCGGCAGGGCGACGATCCTGGAGGCGGAGTCCCGCGGACTCGGTGGCATCACCGTCTCCGAGGCGCTGCGCAGCTGGGCCTACGCGGACCGGTTCGCGCTGCCGTACGCGGCGGTGATGCGGGTCATGCCGGATCACACGCTGCCGGTGTTCTCCCACCTGTCCGTCACCGACGCGGGGGCGCAGAGCGCCGATGCCGGGGGCGTCGACTGGGCCACCGTGCCGGCCGGGGAACTGCCGGAGCTGGTGCTGAAGGTGACCCACGAGCAGGTGGCCGCCGAGCTCAACCTCGCGGTGGACGACATCGCGATCGACCAGCCCCTGCTGGAGCTCGGTGTCGACTCCGTGCTCACCGTGGCACTCCGGGTACGGCTGCACCGGTGTTTCGCGGTGGACCTGCCGCCGACGATCCTGTGGAGCAACCCGACGGTCCGCGCCCTCGCGGAGTTCCTCGCCGCCGAGGTCGGCGGTGCCACCGCGGACGCCGAGGAGACCGACCCGGTCGCCGGCCTTCCCGCACCTCAACAGGGATCGGGAACTGCCGAGCAGCTCGACGCCGTCGCGGCCGCGGCCGGGTGA	MAENVQNPPVEPLAVIGMSCRFAPDLDTPGRLWEFLRAGGSAVGEMPDRRWDPYVTDSRTRDILRTTTRKGSFMRDIEGFDAEFFQITPREAEYIDPQQRIMLELAWEALCDAGLPPTSLAGTDASVYVAANSNDYGRRLLEDLDRTGAWAVNGTTFYGIANRISYFLDAHGPSMAVDTACAGSLTALHVAGQALHRGETSVAIVGGINIMASPALVVALDAASATSPDGRSKSFDKAADGYGRGEGGGVVVLKRLSDAVRDGDPVHGLVLASGVFQDGRSDGMMAPNGSAQQRMLEEIYRRSGIDPGTVQYVEAHGTGTQLGDAAEAQAIGNVFGPGRDGDNPLLIGTLKPNVGHVEAASGIAGVIKVLLGMRHGELPPSPHEEPDPGLGLEARGLRLVAEPTPWPRGEHGMRAGVSSYGVGGSIAHAVLQQAPPRPDRTERPAAAATGRPQVFPLSAASEQGVRGLAGSVAAWLRAHPETALDDLAHTFTARRSHLSRRAAVVAGTTEELLGGLDALAGGEKSPAVALASASGFGDGGAAGPAWVFSGHGAQWSGMGRELLTTEPVFAQVIDELAPVFSEELGWTPREAIEAGGPWTVVRTQAMTFAMQVALAEVWSDLGLRPGAIIGHSVGEIAAAAVAGSLDRAEAARFACRRARALGKIAGRGAMAMVPMAFADVEQRVAGRDAVVAAIAASPLSTVVSGDTAAVEALLADLEADGIQARRVNTDVAFHSPHVQEILDEVRQAAAALRAGTPRVTLYSTALADPRSDAPREGEYWATNLADPVRFHQAVRAALDDGTRVFLEVSSHPVVAHSITETALDAGVPDAHVAITLRREQPEQRTVLANLARLHSLGTPVTWSYDGDLVDVPAVRWQHKPYWIFPDTAPEQGAGLGHDPQTHTLIGARTTVASAPVQRVWQTELHMENRPYAQSHKVVGVETVPASVVLNSFITAATNEGERACGLRDIVFRIPLAAHPTRVVQVVLEQDKVRIASRIKRDQESGGVRDDEWLTHTTATVVHEPEVGARPMEDPDVIRARCPVSWTWAKVDGIFRTMGVDGYTFPWVVEELLRGEDEQFSTITVDHTPKLHPSSWTAVVDAALTASGVLVMDENSNVLRTCSHLESLSFVGPPPPRIHVHTVRDPRTPDTISMTVADESGAVVCEARGLRYVKVQDIGSGAVGPRDLVHELAWEPVEVPADAPVPSQALVVGGAAGGPALVEALTARGVRARAVPDATAIGDASLTCADVVVVAPEALLPGEAPEQAARRCAQLLVDAVQQVAAVPDERRRPRVWALTREVRAGATEAALAHAPLWGAGRIVAGERPDLWGGVIDVAENAVPQQVASLIGALPHTEDVLSLDSEGVTAARLRQVARPAEREPVDCRPDGTYLVTGGLGALGLEAARHLVEQGARRLVLIGRRGLPSRSRWDQVDDPAVAAQIAEVVALEAAGATVRVLSLDISDAEATARALDPGALDMPPVRGIVHCAGVVSDALVEKTGAANLDTTMGPKADGAMVLHRLFPAGTLDFFTMFSSCGQLARLTGQVSYASANSFLDALAALRRSRGETGTTSFAWAQWIGRGMGETTGRATILEAESRGLGGITVSEALRSWAYADRFALPYAAVMRVMPDHTLPVFSHLSVTDAGAQSADAGGVDWATVPAGELPELVLKVTHEQVAAELNLAVDDIAIDQPLLELGVDSVLTVALRVRLHRCFAVDLPPTILWSNPTVRALAEFLAAEVGGATADAEETDPVAGLPAPQQGSGTAEQLDAVAAAAG	MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFSELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLADALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRATRPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRCVAALFQRYGAVPDERRLAFYRLLDEFF	666.29	gnl|BL_ORD_ID|939|hsp_num:0	1018			294	474	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0000960.1|Azinomycin_31 # 43851 # 44078 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658	BGC0000960.1|Azinomycin_31 	43851	44078	+	Loose	500	23.8682	APH(3'')-Ib	40.0	3002639	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	GTGACCGGCCGGCCCGGGGTGACGACGATCTCGCCACCCCGGGCCGTCCGGGCCCGGGACGGCGCGACCCACCTGTCCCGGGCCCGGCTCGTTGCAGCCTTTCCAGAGGGTCGTCGCAGTATAGGTGCAGTATTTGTAGTATTGTTTCGGCAACGACTGCGGGTTTTCGTGTATGACGTCGCACCGCAGAGGGGAAGCCCCACATGCCAGGTCAGGACTCAGTGCTGA	MTGRPGVTTISPPRAVRARDGATHLSRARLVAAFPEGRRSIGAVFVVLFRQRLRVFVYDVAPQRGSPTCQVRTQC	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	28.09	gnl|BL_ORD_ID|1690|hsp_num:0	1830			267	357	streptomycin
BGC0000960.1|Azinomycin_32 # 44054 # 44827 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.660	BGC0000960.1|Azinomycin_32 	44054	44827	+	Loose	750	26.9498	adeF	34.92	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCAGGTCAGGACTCAGTGCTGATCGAGGAATCGATACCTGGAAGGTTGCGCGCCGATCACTTCGCTCAGCACGGTTGGGCACACGGCCGCCTGAGCGTGCCCACCGAGGGAAGCGACTGGGAGCAATTCGCCTCGGCCTGGGACGAACTCGTCCCGGACCCCTACCTCGGCGAGGAGCGGTGCCGTCGCAACCGGCGGTTCGGCAGGGTGCTCGCGCACCGGGACGGTGCGCTGGAGCCGCTGCGCGGATCCGACTTCTTCCAGAGCAAGGAGATCAACCGCGCCTTCGGCGGCCGGCTGCGCGTGTTCGAGCCGCTGACCGATGCCGTACTGACGGGTCCTTGCCTTCCCCGGTTGCTGCGCGAGACCGTCGCCGTCGTCAACGAGGCGGCGGGGAAGCAGGACTGGGAACTCGGCATCCACTTCATCCGGGTCATCGCGGATCCTGGTGAAAGCTCGGAACCGGCACCGGAGGGCCGTCATTCGGACGGTCACGCCTACGTGGCCATACACCTGATCGACCGGCACCAGTGTGCCGGAGGACGTAACCAACTGTTCCGGAACAACGAGTCGCGGGCACAGTTCTCGGTCGTCATGACCGAGCCGCTGGAGACCCTGATCGTGTCCGACACGACGATGGAACACAGCGTCAGCGAGATCCGGCCCGAAGCCGGCACCGGGTCCGGCTGGCGGGACACCATGATCGTCGACTTCAACCGTGTGCCCGTCCCGGAGGAAGTGACAGGACGCACGTACGGATTCATCCGGTGA	MPGQDSVLIEESIPGRLRADHFAQHGWAHGRLSVPTEGSDWEQFASAWDELVPDPYLGEERCRRNRRFGRVLAHRDGALEPLRGSDFFQSKEINRAFGGRLRVFEPLTDAVLTGPCLPRLLRETVAVVNEAAGKQDWELGIHFIRVIADPGESSEPAPEGRHSDGHAYVAIHLIDRHQCAGGRNQLFRNNESRAQFSVVMTEPLETLIVSDTTMEHSVSEIRPEAGTGSGWRDTMIVDFNRVPVPEEVTGRTYGFIR	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	24.27	gnl|BL_ORD_ID|132|hsp_num:0	153			2271	2454	tetracycline
BGC0000960.1|Azinomycin_33 # 44892 # 45503 # 1 # ID=1_33;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.698	BGC0000960.1|Azinomycin_33 	44892	45503	+	Loose	350	26.1794	IND-17	23.53	3007470	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	GTGCTCACACTGCCCGGAACGGCATCGGCACCGGAGTTCCGCCTGATCGACATCGACGGCCTGCTCAACAACCGGGCGACGACCGACGTCCGCGACCTCGGCTCCGGGCGGCTGAACGCCTGGGGAAACTCCTTCCCGGCAGCGGAACTTCCCGCGCCCGGATCCCTGATCACGGTGGCCGGCATTCCCTTCACCTGGGCGAACGCGCACGCGAGGGGGGACAACATCCGGTGCGAAGGACAGGTCGTCGACATCCCGCCGGGCCAGTACGACTGGATCTATCTCCTCGCCGCCTCGGAACGGCGCAGCGAGGACACCATCTGGGCCCACTACGACGACGGGCACGCCGATCCGCTCCGGGTCGGAATCTCGGACTTCCTGGACGGCACCCCCGCGTTCGGAGAGCTCAGTGCCTTCCGCACCTCCCGGATGCACTACCCGCACCACGTCCAGGAAGGGCTGCCCACCACGATGTGGCTGACCCGCGTGGGGATGCCGCGCCACGGGGTCGCCCGGTCCCTGCGGCTGCCGCGTTCGGTCGCGATGCACGTCTTCGCGCTCACCCTGCGGACCGCGGCCGCCGTACGACTCGCGGAAGGGGCGACGACATGA	MLTLPGTASAPEFRLIDIDGLLNNRATTDVRDLGSGRLNAWGNSFPAAELPAPGSLITVAGIPFTWANAHARGDNIRCEGQVVDIPPGQYDWIYLLAASERRSEDTIWAHYDDGHADPLRVGISDFLDGTPAFGELSAFRTSRMHYPHHVQEGLPTTMWLTRVGMPRHGVARSLRLPRSVAMHVFALTLRTAAAVRLAEGATT	MRKSIRFLIISVLFLSQFVNAQVRDFVIEPPIKPNLYIYKTFGVFGGREYSTNAMYLVTKKGVVLFDVPWQKTQYQSLMDTIKKRHNLPIIAVFATHSHDDRAGDLSFYNNKGIKTYATVKTNELLKKEGKATSSEITKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNILDGGCLVKSRNATDLGYTGEANVKQWPLTMAKLKSKYPGATMVVPGHDEWKGGGHVEHTLELLNENKK	83.88	gnl|BL_ORD_ID|4962|hsp_num:0	5955			507	660	
BGC0000960.1|Azinomycin_35 # 46593 # 47456 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.707	BGC0000960.1|Azinomycin_35 	46593	47456	+	Loose	350	31.5722	vanD	25.25	3000005	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGCCCATAGCCGTGGTCGCCTCCCGGATACGCCGCGAGGAGCGGCTGATCCTCGAAGCGTTCGAGCGGCTCGGGCTGCGCTGCGAGCACGTCGATCCGCGCGGGCTCAGGCTGCTGCTCGCCGACGGCCGGCCGCCCTACCGGGCCGCGCTCATGCGCGAAGTGAGCCACAGCCGTGCCGCCTCCGTAGCGACCACGCTGGAAGCGCTCGGGGTCCCCACCTACAACAGGCCCCGCGTACTGGACGTCTGCGGCGACAAACTGCGCACCGCCCTCGCCTTCCACAGCGCCGGGCTCCGGATGCCGCAGGCCGCGGCGACCTGGGGCACGGGGGCGGCCCTGGAAGCGATGCCCAAGCTCGGGTACCCCGTCGTGGTCAAACCCGTCACCGGTTCGTGGGGACACCTGACCACGCGCGTCCGCGACGAGGAGCAGGGCCGGGCCGTTCTCGAACACCGTGCCGCCCTGCCGAACCCGCAGCAGCACGTCTTCTTCCTGCAGGAGCACATCGACAAACCCGGGCGCGACATCAAGGCCTACGTCGCGGGTGACCGGGTGATCTGCGCGATCTACAAGAACGCGGTCGACGACTGGCGGACCAACACCGCCATCGGAGGCGCGGCGACCCCCTGTCCGATCACCCCCGAACTGACGGAGCTCGCCGTCGCGGCGGCACACGCGGTAGGAGGCGGGTTCCTCGGCGTCGACCTGCTCATCGACCAGCAGGAGCGCCTCTACGCCAACGAGGTCAACCACACCCCCGAGTTCCACGGCGCCGTCGACGCGACCGGGATCGACGTCGCGCAAGGCATCGTCGAGTGGGCCGTCGCGGAGATCGAGGCACAGGAAAGGGCGGCGGCATGA	MPIAVVASRIRREERLILEAFERLGLRCEHVDPRGLRLLLADGRPPYRAALMREVSHSRAASVATTLEALGVPTYNRPRVLDVCGDKLRTALAFHSAGLRMPQAAATWGTGAALEAMPKLGYPVVVKPVTGSWGHLTTRVRDEEQGRAVLEHRAALPNPQQHVFFLQEHIDKPGRDIKAYVAGDRVICAIYKNAVDDWRTNTAIGGAATPCPITPELTELAVAAAHAVGGGFLGVDLLIDQQERLYANEVNHTPEFHGAVDATGIDVAQGIVEWAVAEIEAQERAAA	MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWENYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYVGCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFGVNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGSIVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR	83.67	gnl|BL_ORD_ID|759|hsp_num:0	824			384	936	vancomycin; teicoplanin
BGC0000960.1|Azinomycin_36 # 47453 # 48184 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.669	BGC0000960.1|Azinomycin_36 	47453	48184	+	Loose	700	26.9498	tet(47)	30.14	3004613	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGCGCGACGGCCGGTCCCCCCTCGTTGCTCGCGCTGTGGAGCGCGCCCCGCTCCCGCTCCACGGTGTTCTTCCGGATGATGGTGGAACGCCAGGACGTCCTGGCGCTGCACGAGCCGTTCTGCAACATCGCCAACGACGGCAGCACCGTGATCGACGGCCGCGTGGTGCACAGCACGGACACCCTGACGGACACGCTCATCGGACTCGCGGCACAGCGAACGGTGTTCTTCAAGGACACCACCGACTGCTTCTACGACTCCGTGTTCGCACGTCCGGACTTCCTCAAGAGCGGGCACCACGCCTTCCTGCTGAGGAACCCGAAGGAGATCATCCCGTCGTACGCGGCCATCAAGCCGGACATGGCCTGTCACGAAGTGGGCATCGCCTACCTCCACCGGATCCACCAGGCGGTACTCGACGCCGGCGGCAGTGCGGTGATCCTGGACTCCGACGACTTCGTGGACCACCCGGAGGCGACCGTCCGGCAGTACTGCGCGACGGTGGGCCTGCCCTTCCGCGCCGACGCCCTCCAATGGCAGCCGGGTCAGCGGCCGGAGTGGAGCCAGTCCGCGCGCTGGCACACGGATGTCAGCGCCACGTCGACGATACGGCGCCGCGAGCGGACCTACGACAGGACGACGGACAACGACCCGCTGCTGCAACGCTTCTACGAACACCACATTCCCTTCTACGAGTACCTGTGGGAGCGGCGGCTCCGGATCTCCTGA	MSATAGPPSLLALWSAPRSRSTVFFRMMVERQDVLALHEPFCNIANDGSTVIDGRVVHSTDTLTDTLIGLAAQRTVFFKDTTDCFYDSVFARPDFLKSGHHAFLLRNPKEIIPSYAAIKPDMACHEVGIAYLHRIHQAVLDAGGSAVILDSDDFVDHPEATVRQYCATVGLPFRADALQWQPGQRPEWSQSARWHTDVSATSTIRRRERTYDRTTDNDPLLQRFYEHHIPFYEYLWERRLRIS	MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE	58.55	gnl|BL_ORD_ID|4799|hsp_num:0	3308			570	774	tetracycline; oxytetracycline
BGC0000960.1|Azinomycin_37 # 48254 # 49513 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.675	BGC0000960.1|Azinomycin_37 	48254	49513	+	Loose	1700	26.5646	LpeB	35.29	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATTATTTCCAAGCCCCCGTTCTGCCCGGTGCAGTTCCAGGACTCCGACCTGCTCAACTCCGGATTCCACGCCGCCACGGACATGCACGCGCTCTGGGCCGACCTGCGTGAGAACCAGCCGCTCTACCGGGCCGACCCCGGCGGTGGCCGGGAGCCGTTCTGGGTCGTGACCCGCCACGAGGACGTCAGCCGGGTGCTGCGCAGCCACGGGGAGTTCTCCTCCCGGCGGGGCACGATCCTGTGCGTGCTCGACCTCAACACCGCGGACATCGCGTCCGACAACATGATGGCCGACACCGATCCGCCCCGGCACCGGGAGTTCAGGGAGCCGCTCAACAAGGCGTTCGCCCCCTCCGTGGTCGCCACTCAGGAGCGGCTGCTCAGAGAACTGTCGCAGGACCTGATCCAGTCGGTCCTGGAAGCCGGCGTGTACGACATCGCCCACAAGACGATGATGTTCCCGATGGCCGTCACGGGCACGCTCATGGGCCTGCCCCCCGAGTCCTGGGAAAGGCTCGCGGAGCTGGTCATGATGACGATCGCCTACGACGACCCCGACTACTCCGCCGGCAGTGCGCAGGCCACCGTGCGCCAGGCCCGGCACGAGCTGTTCGAGTACTTCCAGAAGGAGTACGCGCAGCGGAGCCGGGACGACGTCGACCCCGACGTCATCGGCGCGATGGTCGGCATGGATCTCTCGGAAGGACCGATGACGCAGGAGCAGGTCCTCCTCAACGCCTTCGTGCTGCTCATCGGCGCGAACGTCACCACGCCGCACGCCCTGTGCACCCTGATGTCCGTGATGGCCGAACACCCGGAGCAGTACCGGGCCGTACAGGAGAACCCCGAGCTGCGGGCGTCCTGCCTCCAGGAGCTCCTGCGCTGGTCCTCCCCGGTCACCGCGCTGATGCGGTACGCCGTCAAGGACGTGGAGATGCACGGCCGAACCATCCGGGCGGGCGAGCCGGTCACCGCGTGGATCGGCGCGGCCAACCGGGACGAGAGGGTCTTCCCCGACCCCTACACCTTCGATGTCGCACGACGGCCGAACAAGCACCTCGCCTTCGGCCTGGGACCGCACTACTGCATCGGCGCCAACCTGGCCAAGGTCGGCCTCGACATCTTCCTCGACGAACTCCTGGAGCGGGTGGAGAGCATCGAGATCGCCGGCGAGGTGAAGCACGTCGCCTCCCACTTCGTGCCCGGCTACAAGAGCATGCCGGTGCGGTTCACTCCTCGTGAGGCACACGTACGGTGA	MIISKPPFCPVQFQDSDLLNSGFHAATDMHALWADLRENQPLYRADPGGGREPFWVVTRHEDVSRVLRSHGEFSSRRGTILCVLDLNTADIASDNMMADTDPPRHREFREPLNKAFAPSVVATQERLLRELSQDLIQSVLEAGVYDIAHKTMMFPMAVTGTLMGLPPESWERLAELVMMTIAYDDPDYSAGSAQATVRQARHELFEYFQKEYAQRSRDDVDPDVIGAMVGMDLSEGPMTQEQVLLNAFVLLIGANVTTPHALCTLMSVMAEHPEQYRAVQENPELRASCLQELLRWSSPVTALMRYAVKDVEMHGRTIRAGEPVTAWIGAANRDERVFPDPYTFDVARRPNKHLAFGLGPHYCIGANLAKVGLDIFLDELLERVESIEIAGEVKHVASHFVPGYKSMPVRFTPREAHVR	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	41.32	gnl|BL_ORD_ID|2387|hsp_num:0	2759			528	627	erythromycin; spiramycin; azithromycin
BGC0000960.1|Azinomycin_38 # 49510 # 50274 # 1 # ID=1_38;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.699	BGC0000960.1|Azinomycin_38 	49510	50274	+	Loose	400	31.9574	vanR gene in vanF cluster	28.24	3002925	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGAGCAGCTACCCCGTGCACCGCTCCGACGCCCGGCTGTGGTTCGACGGCCGGTTCCGCTCCGCCACGGCGACACACAGTCTGTACTGCCTGCCCTTCGCCGGTGGTTCCGCGACCTACTACGCCGACTGGGCGCCCCACTGCGCGAGCCCCGTCGAACTGGTGCCGGTGCAGCTGCCCGGCCGCGGTGGCCGCATGACCGAGTCGTCGGCCAAGGATCTGGTGCAGCTCGCCGAGGAGATCGCCGACACCATCGCCGCCGAACCCACGCGGACCCTCCTGTACGGGCACAGTATGGGAGCCATGCTGGCGTTCGAGGTGAGCCGACGGCTTCAGACGCTGAACCGGCCGGTGCGGCACCTCTTCGTCAGCGGCCGCCCCGCGCCGACGATCGTGCGTCCGATCGCCCCCGTCAGCCACCTGCCCCGCGCCGAGTTCATCCAGATGCTGCGCGACTACGGCGCCGCCGACCAGACGGTCTTCGAGCACGACGAACTGCTGGACCTGCTCATGCCGATGATCCGGGCGGACTTCGCCATGATCGAGAACTACCGGTACCAGGAGGCACCGCGGCTCTCGTGCCCGATCTCCGCCTGGTGCGGAGACGCCGACCCGGAGGTGCCTCCCACGGCGATGCGTGGCTGGGGCGACCAGACATCGGGAGAGTTCACCCTCTCCGTGCTGCGAGGCGGGCACTTCTTCCTGACCGAGCACCGGGCCGAGATCATGCGGGCCGTACTCGCCGCGGTCCGTCGAGCGCGTTGA	MSSYPVHRSDARLWFDGRFRSATATHSLYCLPFAGGSATYYADWAPHCASPVELVPVQLPGRGGRMTESSAKDLVQLAEEIADTIAAEPTRTLLYGHSMGAMLAFEVSRRLQTLNRPVRHLFVSGRPAPTIVRPIAPVSHLPRAEFIQMLRDYGAADQTVFEHDELLDLLMPMIRADFAMIENYRYQEAPRLSCPISAWCGDADPEVPPTAMRGWGDQTSGEFTLSVLRGGHFFLTEHRAEIMRAVLAAVRRAR	MKNITILIADDDAEIADLVAIHLEKEGYRVIKVSDGQETIDVIQNQPIDLLILDIMMPKMDGFEVTRRIREKHNMPIIFLSAKTSDFDKVQGLVIGADDYMTKPFIPIELVARVNAQLRRFMKLNQPKTKQNSNLEFGGLTISPEQRTVTLYGKNIELTPKEFEILFLLASNPNKVYRAEDIFQKVWGDAYYEGGNTVMVHIRTLRKKLEEDKRKNKLIQTVWGVGYKFNG	109.96	gnl|BL_ORD_ID|298|hsp_num:0	240			24	255	vancomycin
BGC0000960.1|Azinomycin_39 # 50296 # 51456 # 1 # ID=1_39;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.676	BGC0000960.1|Azinomycin_39 	50296	51456	+	Loose	450	26.1794	PAM-1	42.86	3007199	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	PAM beta-lactamase	GTGGACTTCGATGTGCCACCTCAGAGCGTCGACTTCGCGAACGAGGTCGAGGAGATTCTGACGGCCCCGGAGACGGAACGGCTGCTGCGGGAGCTCGCCACCCGGCAGGACGGCATGGACGGCGACCCCCGTGCCTTGTACCGGCATCTGGGCGACGCAGGGATCCTCGCTCCCTCCTGGCCGGTCGAATACGGCGGCAGGGGCGCCGACTTCACCGCGACCGTGGCGCTGCTGGAAAAGCTCGTCGCCCACCGGATACCGCAGAATCTGTACTGCATCTCGGTGCAGAACGTCGGCTCCCTGATCCTGGCCGCGGGCTCGGAGCAGCAGCGCCGGACGCTGCTGCCCGCCCTGGCGAGCACCGAACTCACGTCGTGCATCCTGTTCACCGAGCCCGGCAACGGATCCGACCTGGCAGGCATCACCACGACCGCGGTGCGCGACGGCACCGGCTGGGTCCTCAACGGGCGCAAGACCTACAACCTCAAGAGCGCCTACGCCGACATCGCGCTCATCGCGGTACGGACCGATCCGCAGAGCAGCCAGTACGAGGGACTCACCCTCTTCCTCGTCCCGCTGGACGCACCCGGTGTCGTCATCCGCCCCATTCCCAGCCTGGCCGACGAGCAGTTCCACGACATCTGGTTCACCGATGTGCGTGTCGACGAGTCAGCGCTGTTCGGCCAGGTCGGCGAGGGCTGGTCGCTGATCACTCAGATGTTCGCCGCGGAGCGCACGGGGCTGGACTACTACGCGCGGGGACGCCACTGGCTGGATCTCGTCGCGCAGCGTGTCGACAGGAACGGTGCACGGCAGTCCGATGCCGTACGCACCGAACTGGCCCGTCACGAGGCGCGGATCACCGCGAGCAAACTGCTGAGCTGCCAGGTCATGCAGAACCTTCAGGACGGCAGTCCCGACATCGCCGAATCCTCCTTCGCGAAATGGCACTGCAGCGAATCGGCCCAGCGCATCGCCTGGTGGGCCCTGGACACCCTGGGCCAGGACCTGCTGGAACCCGGGCCCGACCCCGGTGACCGCACTCTGGAGGCAGCCTTCCGGGAGGCACCGGGAATGACCATCTCCGGCGGGGCCTCGGAGGTCATGCTGGACATTCTGAGCAGCGCCCGGGTATTCACCCACGCCCCGAGGGAGGACTGA	MDFDVPPQSVDFANEVEEILTAPETERLLRELATRQDGMDGDPRALYRHLGDAGILAPSWPVEYGGRGADFTATVALLEKLVAHRIPQNLYCISVQNVGSLILAAGSEQQRRTLLPALASTELTSCILFTEPGNGSDLAGITTTAVRDGTGWVLNGRKTYNLKSAYADIALIAVRTDPQSSQYEGLTLFLVPLDAPGVVIRPIPSLADEQFHDIWFTDVRVDESALFGQVGEGWSLITQMFAAERTGLDYYARGRHWLDLVAQRVDRNGARQSDAVRTELARHEARITASKLLSCQVMQNLQDGSPDIAESSFAKWHCSESAQRIAWWALDTLGQDLLEPGPDPGDRTLEAAFREAPGMTISGGASEVMLDILSSARVFTHAPRED	MRFLASLALPLFAANLAVAAPKPLPQLEAYEGLQAWLVPVEPLRISDHVWQIGTASISALLVKTDAGAVLIDGGMPQVADHLLANMKKLGVQPQDLRLILHSHAHIDHVGPLAAIKRATGAVLVSNAESAVLLQRGGADDIHFGSGMLFAPLTPERLVQDGEAVTLGDTTFTVHFTPGHTPGSMSWTWTDTQDGKPLRIAYADSLSAPGYQLRDNARYPHLVDAFRASFAAVRALPCDLLLTPHAEGSGWDYTNAEKPHPAPVSCKAYADKAEQKLDQMLAEQAKSR	134.49	gnl|BL_ORD_ID|4826|hsp_num:0	5812			39	123	ceftazidime; doripenem
BGC0000960.1|Azinomycin_40 # 51462 # 52463 # 1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.723	BGC0000960.1|Azinomycin_40 	51462	52463	+	Loose	1650	28.4906	Listeria monocytogenes mprF	43.75	3003770	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGGACCTGCGACCTGATCCGTTCCAGCAGCGTCTGCGCAGCGCCGTGGACACGGTCCTCACGCGCACCGGCGACCTCCCCGCTCAACTGGCGGACATCGGCGTGCCCTCCCTCGGCGCACCGGAGCGCCTCGGCGGCTTCGCGCTCGGACTCAGCGCCGACATCGTCGTGAACGAACGCCTCGGACACGGACTCGAACCGCTCGACAGCTATCGGGCGACCGCGTTCGCGCTCGACCTGCTCGACTGCGACGGCGCACCCACGGAACTGCTGGCCGAGATCCTCGCTGACCTGTACAAGGGCACCCGGCACGCGGTGGTCGTGGGGGCGCGAGGCGGCGGCGCCGTACAAGTGCGGGACGGAGGCCGGCTGTGGGGCGAGTCGGAATCGCTGCCTGCGGGTGACATCGCGCTGTGCATCGTGCGAACCGCCGGCGAGGACGGCGCCGCATGGCGTCTGGCGATTCCGGAACCCGGCACCTGCGTCACGGAGCCGGCGGAGCATCTCGGCATACCCGCCTCGCGATTGAGATTCCACGGTGCGCCGTCCCAGTCTCTGCCGGTGACCACCGCTCACTGGCAGCGGGCCCTGGCGGCGGCGCGGATCCGGCAGGCGGCACTGCTGCTGGGCATCGCCGACTGGATCACCGATGTGGCCCGCGCCCATGTCAACACCCGCACGCAGTCCGGCAAACCGCTCGTGGAGCGGCAGACGGTCGCCCACCGGCTGGCCGTCCTGATCGGCGAGGGGGAGGGCTGGAAGCTCCTGCTGAACAAGGCGGCCTGGGAGTTCGACCGCGGCGGGCGCCCCGACGCGGCGGCGATGCTGGCGGTCGCCGGCGAACACGCGCAGCTCGCCAGCCGCATCGCCCTCCAACTGCACGGCGTACGGGGAATGCTCGCGCACTCGACAGCGGCATCCGTGTACCGGATGGTGGCCGTGGAGTCGGCGCGGCTGGGCACCCCCGCCGCGCTGTGGCGGGAAGCCGGATCCGCCGCCTGA	MDLRPDPFQQRLRSAVDTVLTRTGDLPAQLADIGVPSLGAPERLGGFALGLSADIVVNERLGHGLEPLDSYRATAFALDLLDCDGAPTELLAEILADLYKGTRHAVVVGARGGGAVQVRDGGRLWGESESLPAGDIALCIVRTAGEDGAAWRLAIPEPGTCVTEPAEHLGIPASRLRFHGAPSQSLPVTTAHWQRALAAARIRQAALLLGIADWITDVARAHVNTRTQSGKPLVERQTVAHRLAVLIGEGEGWKLLLNKAAWEFDRGGRPDAAAMLAVAGEHAQLASRIALQLHGVRGMLAHSTAASVYRMVAVESARLGTPAALWREAGSAA	MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRASFYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYFPILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPDYLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVSHTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEIIEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASMMPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE	38.50	gnl|BL_ORD_ID|2056|hsp_num:0	2279			942	1038	defensin
BGC0000960.1|Azinomycin_41 # 52571 # 53686 # 1 # ID=1_41;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.691	BGC0000960.1|Azinomycin_41 	52571	53686	+	Loose	550	29.6462	GES-32	41.86	3006161	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GES beta-lactamase	GTGAAGGCCAGCTGGAGACAGGTATTTGCGTGGCGGATGCAGCGGCAGTTCCTGGAGCCGCGTACCCAGCCGAGTGCGAGTGACGTCGTCGGCAGACTCTGTGGCGTGCAGGCACAGGTCTGGAGTGTCGCCGAGCTGAACGTCGCACTTCGGCAGGCGGCACCCGACCGGGAAAGCGTCAACCGGGAGGTCGCCGACCTCTCGTTGATGAAGACCTGGGCGATGCGCGGAACCCTGCACCTCCTGCGGCCGAGCGAGGCCGGGCCCTACCTGTCGCTCATGGCGAACACGGGAAGCTGGCTCAAGCCGTCCTGGACCCGGGCCTCCGGCGTCACGCCCCGACAGGTCGACGAGCTGACCGAAGAGGTGGCGGGAATCCTCGACGGAGTGGTGCTCACCCGGGATGAGCTCGTCACCCGGCTCGTCGCCGACAAGCGGTTCGTGAGCATGGAGGAGCGACTGCGGTCGGGGTGGGGCTCCGTGCTCAAACCGCTGGCCTGGCGAGGCGTCCTGTGCCACGGCCCGAACCGGGGCAACAAGATCACGTTCACGCTGCCGGCGAGCCAGTTCGGTGCGGACTGGGGCAAGATGCCCGAACCCGACGAGGCGGCGCCCACGGTGATCAAGGCCTACCTGGGCGCGTACGGCCCTGCGACGATCGAGACCTTCGACCGCTGGCTGTCGCTCAACAGCACGAGCAAGCCGAAGCTGCGCAAGTGGTTCGGCGACATGGGCGACGAGCTCACCGAGGTCGACGTCGAGGGGCGCAAGGCCTTCGTCCTGACGGAGCACGCGGAGGAACTCGCCGCCACCGCCCCGTGCACCGGCATCAGGCTGCTCGGCGGCTTCGACCAGTACCTCCTCGGCCCCGGAACCAAGGACGAGGTCGTCCTCGCACCGGAACACCGCTCCGCGGTGAGCCGCGCCGCCGGCTGGATCTCCCCCGTGGTCGTGAAGGACGGCAGAGTCGTCGGGGTGTGGGAGATCGTCGACCAGGAGCTGGTGGTGACCCCGTTCCCGGACACCGAACGGCTCCCTGTGAAGGCGGTCGAGAAGGAGGCCGCGCACGTCGCCCGCGCCAGCGGAGTGAGCCGGCTGCCGGTGCGCATCGTCTGA	MKASWRQVFAWRMQRQFLEPRTQPSASDVVGRLCGVQAQVWSVAELNVALRQAAPDRESVNREVADLSLMKTWAMRGTLHLLRPSEAGPYLSLMANTGSWLKPSWTRASGVTPRQVDELTEEVAGILDGVVLTRDELVTRLVADKRFVSMEERLRSGWGSVLKPLAWRGVLCHGPNRGNKITFTLPASQFGADWGKMPEPDEAAPTVIKAYLGAYGPATIETFDRWLSLNSTSKPKLRKWFGDMGDELTEVDVEGRKAFVLTEHAEELAATAPCTGIRLLGGFDQYLLGPGTKDEVVLAPEHRSAVSRAAGWISPVVVKDGRVVGVWEIVDQELVVTPFPDTERLPVKAVEKEAAHVARASGVSRLPVRIV	MRFIHALFLAGIAHSASASENLTFRTDLEKLEREKAAEIGVAIVDPQGQIVAGHRIEQRFAMCSTFKFPLAALVFERIDSGTERGDRKLSYGRDMIVKWSPAAERFLASGHMTVLEAAQAAVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIAMARTVAKVLYGGALTPTSTHTIERWLIGNQTGDATLRAGFPKDWVIGEKTGTCANGGRNDIGFFKAQDRDYAVAVYTTAPKLSAEQRDELVASVGQVITQLILSTDK	129.27	gnl|BL_ORD_ID|3546|hsp_num:0	4615			531	660	
BGC0000960.1|Azinomycin_42 # 53725 # 54252 # -1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.684	BGC0000960.1|Azinomycin_42 	53725	54252	-	Loose	900	28.1054	msrF	27.4	3005087	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGATCTGGCGAACCGAGGTCCTCGATCAGCTCGACCTGTACTGGGACCACCACTTGATGCCCAGGCTGGCCGGTCTCACCGACGACGAGTATCTGTGGGAGCCGGTGGCGGACTGCTGGTCGGTCCGCGTCGGCGAGGACGGAAGGGCCTCGCTCGACCTGCGACGCCCCGCCCCCGAGCCGCCTCCCGTGACGACGATCGCCTGGCGCATGTGCCACGTCGCCTTTCACGTACTGGGCATCCGGTCCAGCGCTCACTTCGGCGACGGATCACTGACCTTGGAGACCGCGTCCATCCCCGTCACGGCCGCGGACGGGCTCGGGGCGCTGCACGAGCACTACCACGCATGGCGCAAGGGGGTGCTCTCCCTCGACGACGCGGAACTGGCGCGGCCCATAGGAGATGTCGAGGGGCCGTGGGGAGAGCGGCCGATGGCGACCCTGCTCCTGCACGTCAATCGTGAAGTGATGCATCACGGAGGGGAGATCGCCCTGCTCCGCGATCTCTACCGCGCCCGCTTCGCGTGA	MIWRTEVLDQLDLYWDHHLMPRLAGLTDDEYLWEPVADCWSVRVGEDGRASLDLRRPAPEPPPVTTIAWRMCHVAFHVLGIRSSAHFGDGSLTLETASIPVTAADGLGALHEHYHAWRKGVLSLDDAELARPIGDVEGPWGERPMATLLLHVNREVMHHGGEIALLRDLYRARFA	MEQICFELENVEVTFLDKKILEIDRLAVHQFDRIGIVGKNGAGKSTLLKILGGIIKPTRGKVNRYIDYGYFEQVESPKVSMADPRLLGKLNVKVDSNNLSGGELTRLKIAQLFTDYYESLLIDEPTTHLDQDGISFLIDKLKYYYGALVLISHDRNLLDELVTTIWEIDDGMIKVYSGNYSEYLRQKKVEREQQAHDFDLYLKEKNRLEKAAKEKMNKAEKIANSSSMSKKESKAKANRMFESKSKGTSQKSLQRAAKAVEKRIEQLEVVDAPKEIHTIQFHQTHSTPPLHNKFPILGDRLTLQAGDKTLLEETSFQFPLGKTIAITGNNGSGKTTLIHHIIQKGEGITISPKAVIGFYEQMGYQFNEDKTVLSYMKARSDYDESKIRSVLHAMNFNGNDLKKNVRYLSGGEATRLVLCQLFLGRYNILILDEPTNFLDIFCIEALERFIEEYEGTIILISHDKKFVDHVSDTIYKIENKKLNLVN	36.01	gnl|BL_ORD_ID|2804|hsp_num:0	3821			816	1035	erythromycin
BGC0000960.1|Azinomycin_43 # 54572 # 54958 # 1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.718	BGC0000960.1|Azinomycin_43 	54572	54958	+	Loose	725	23.8682	EC-18	38.89	3006878	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	EC beta-lactamase	ATGAGTGATCGCGTCCAGGTGACCGTCGACGCGCACGACCCGCGCGCGCTGTCGTCCTTCTGGAGTGCCGCATTGGGCTACGTCCACGTCGGCGCGGAGGGCGAGCGCGACACGCGCGCGGTGCTGGAGGACCCCGAGGGCCGGGGGTACCGGCTGTCGTTCCGGCGGGTGCCGGAGGCCGAGGGCACCGGGAACCGCCTCAGCATCGCGGTCCACCCGGCCCCCGGGCTGACGGGCGAGGAGCGGATGACGGCGCTGGAGGCCGAGTGCGAGCGGCTCCTCGCACTCGGGGCGACGCGCGTACGCCGCCAAGAGCCTGCCTCCGTGATCGACACCGGCCACATAGTGATGACGGACCTCGAAGGCAACGAGTTCCGTCTTGAGTGA	MSDRVQVTVDAHDPRALSSFWSAALGYVHVGAEGERDTRAVLEDPEGRGYRLSFRRVPEAEGTGNRLSIAVHPAPGLTGEERMTALEAECERLLALGATRVRRQEPASVIDTGHIVMTDLEGNEFRLE	MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARFAAAWQILNALQ	33.95	gnl|BL_ORD_ID|3523|hsp_num:0	4592			900	954	
BGC0000960.1|Azinomycin_44 # 55483 # 56232 # -1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.689	BGC0000960.1|Azinomycin_44 	55483	56232	-	Loose	500	35.039	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	26.52	3003393	protein variant model	I194T	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGGACCGACTTGCAGGAAAGCACGCACTGATCACCGGGGGGACGAGCGGCATCGGCCTGGAAACGGCCCGCGAATTCCTCGCCGAGGGAGCGACCGTGGCCATCACGGGCCGTTCGCGGGAGAAACTGGAGGAGGCGGCCCGGGAGCTGGGCGGCCCGCTGCTGACCATCGTCAGTGACGCCGGCGACGTACCCGGCCAGGCGGCGCTCGCGGCGCGTCTGCGGGAGGAGTGGCCGAAGCTCGACATCCTGATGAGCAACGCCGCCGACATCACCCACCTCCCCATCGAGGCATGGACCGAGGAGGCGTTCGACAGGCTCGTAGCGACCAATCTGAAGTCGCCGTTCTTCCTGATCAGGGACCTGCTGCCGCTCTTCTCGCGGCAGTCCTCGGTCATCCTCGTGGGCTCGGTCTCCGCGTACATCGGACACGACAACGCGGCCGTCTACGGCGCGGCCAAGGCGGGTCTGCTCTCCTACACGCGAGGGCTGACCCATGAGCTGAAGGACCGGGGCATCCGCGTCAACGGACTGAGCCCGGGTCCGACGATCACCAATGCGTTCGCGTCCCTCGGCCCCGAGCGCCAGGCCGCCCTCTACGAGGAACTCCGGCAGACCGTGCCTCTGCATCGCCTGGGCACCGCCACCGAGCTGGCGAAGGCGGCGGTCTACCTCGCCTCGGACGAATCCGGCTACACCGCGGGGACCGTGCTGCGCGTCGACGGAGGCATCGGGCAGCTCGCGTACTAG	MDRLAGKHALITGGTSGIGLETAREFLAEGATVAITGRSREKLEEAARELGGPLLTIVSDAGDVPGQAALAARLREEWPKLDILMSNAADITHLPIEAWTEEAFDRLVATNLKSPFFLIRDLLPLFSRQSSVILVGSVSAYIGHDNAAVYGAAKAGLLSYTRGLTHELKDRGIRVNGLSPGPTITNAFASLGPERQAALYEELRQTVPLHRLGTATELAKAAVYLASDESGYTAGTVLRVDGGIGQLAY	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	92.57	gnl|BL_ORD_ID|1964|hsp_num:0	1574			12	789	isoniazid
BGC0000960.1|Azinomycin_46 # 57036 # 57713 # 1 # ID=1_46;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.683	BGC0000960.1|Azinomycin_46 	57036	57713	+	Loose	375	41.9726	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	30.93	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCAGTCGTTCAAGAAGTGTCGCGACGGAAGCTACGACTTCTTGAACGCCAAGTCAAGAAGTCGTAGGATCTGTCCCGTGGCACGAACCGGACGCCCCCGCGAGTTCGACAAGGAACGGACGCTGGAGCGCGCACTCGAACTCTTCTGGTCCCGGGGATACGGGGCGACGTCGATCCAGGACCTGGTCGACGCGCTGGCGGTCGAACGCGGCAGCCTCTACGGCGCGTTCGGCGACAAGCGCCGCTTCTACCTCGAGGCCGTCAGGCTCTACTGGGAGGTGTACGAGCGGCACCTGACCGCCGCGCTCGACACCCGCCCCCTCCTGCCCGCCCTGCGGGAGATCCTGACCCATCCCGCGCGGCTGGACGAACTGATCTCCGACCTGGGCGTCCCACAGGGCTGCCTGATCGGCAACACGACCGCCGAGCTCGTCCCCCAGGACAGCGAAGCCACGCAGATCGTCACCCGCTCGTACCACCGGTTCACCGACATCGTCGCCGCTGCGCTCCGCCGCGCACAGGCCGACGGAGAGGTCACGGACACCTGCTCCCCCGAGGCCCAGGCACAACTCCTCCTCTACATCGTCCAGGGCCTCTCGCTCGTATCGAGGGCGGGGCTCGACAGGGCGGCGGCCCTGGCGGCGATCGACACGGCGCTGGACGGACTGCGGGCATGA	VQSFKKCRDGSYDFLNAKSRSRRICPVARTGRPREFDKERTLERALELFWSRGYGATSIQDLVDALAVERGSLYGAFGDKRRFYLEAVRLYWEVYERHLTAALDTRPLLPALREILTHPARLDELISDLGVPQGCLIGNTTAELVPQDSEATQIVTRSYHRFTDIVAAALRRAQADGEVTDTCSPEAQAQLLLYIVQGLSLVSRAGLDRAAALAAIDTALDGLRA	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	104.65	gnl|BL_ORD_ID|2090|hsp_num:0	2306			9	285	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000960.1|Azinomycin_47 # 57874 # 58323 # 1 # ID=1_47;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=14bp;gc_cont=0.709	BGC0000960.1|Azinomycin_47 	57874	58323	+	Loose	300	26.5646	tet(36)	50.0	3000197	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGACAGTGCAGCTGACGATCGACTGCTCCGATCCGCGGACAATGGTGGCGTTCTGGGCGGAGGCCCTGGGCTACGTGCCCGAGCCCGCGCCGGACGGGTACGCGACGTGGGGCGCTTACTGGGAGGCGACGGGGGTGCCCGCGGAAGAGTTGCCGGCCGGGGCAGGCGACACCGCGGAGTCGATCGTCGATCCGGCGGGTCGCGGGCCCCGTGTGTGGTTCCAGCAGGTTCCGGAGCCGAAGGCCGCCAAGAACCGGTGGCACTTCGACCTGAAGGCCGGTGGCGGCCGTGACGTCCCGTTGGACGTCCGCGCGCGGCGGGTCAGGGCCGCTGTGGACCGGCTGGTCGAAGCCGGTGCCACCGTGGTGAAGATCAAGGATGAGCCGCGCACGGGGCTTTACGCCGCGGCCATGCAGGACCCCGAGGGCAACGAGTTCGACGTCGTCTGA	MTVQLTIDCSDPRTMVAFWAEALGYVPEPAPDGYATWGAYWEATGVPAEELPAGAGDTAESIVDPAGRGPRVWFQQVPEPKAAKNRWHFDLKAGGGRDVPLDVRARRVRAAVDRLVEAGATVVKIKDEPRTGLYAAAMQDPEGNEFDVV	MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRASTTSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLEIPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETILEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFIETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFYSGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRSKLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTIYKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFDGVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPILDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQGLGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK	23.28	gnl|BL_ORD_ID|1675|hsp_num:0	1708			1323	1389	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000960.1|Azinomycin_48 # 58792 # 59205 # -1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.681	BGC0000960.1|Azinomycin_48 	58792	59205	-	Loose	1050	23.8682	lmrC	43.33	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGCCAAGGCACCGAGACGCGGGCCCTACATCTGCGGCATCGACGCTGCGCTCGACGTGGTGAGCGGCAAGTGGAAGGGACTGATCCTCTGGGAACTCGACGCCCATCGCGTACGCCGTTTCGCTGAGCTCCGTCGCGGTCTGCCGGGGGTGAGCGAGAAGATGCTGACGCAGCACCTGCGCGAGATGGAGGAAGACGGTCTCGTGCACCGAGAGGTCTATGCCGAGGTGCCGCCGCGGGTGGAGTACTCCCTGACCGAGCACGGGCGCACGCTCAACCAAGCGCTCGGACCGCTCGGCGCCTGGGGGGTCGAGCGGATGCGCCGCGAAGGCTCCGAAGCGGTCGCCGTGACCGAGACCTCACACGAGGTAAGCGTCCCGGCCGGCAACCCTGTGCGTGGGTGCCACTCCTGA	MAKAPRRGPYICGIDAALDVVSGKWKGLILWELDAHRVRRFAELRRGLPGVSEKMLTQHLREMEEDGLVHREVYAEVPPRVEYSLTEHGRTLNQALGPLGAWGVERMRREGSEAVAVTETSHEVSVPAGNPVRGCHS	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	24.91	gnl|BL_ORD_ID|900|hsp_num:0	974			951	1029	lincomycin; clindamycin; celesticetin
BGC0000960.1|Azinomycin_49 # 59290 # 60198 # 1 # ID=1_49;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.667	BGC0000960.1|Azinomycin_49 	59290	60198	+	Loose	700	30.8018	tet(X4)	27.18	3004720	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGAACGAACAACAGAACCACACCACCAGGCAGGACAGCACTGTCACCGTGATCGGGCTCGGCCCGATGGGCCAGGCGATGACCCGCACCCTCCTCACCGCCGGCCACCCGGTCACCGTCTGGAACCGCACCGCCGGTCGGGCCGACGGCGTCGTCACCGACGGAGCGACGCTCGCGGCGACACCCAGCGAAGCGGTCGAAGCGAGTGACCTCGTGATCCTCAGTCTCACCGACTACCAGGCGATGTACGACATCCTCGGCAGCGCCACCGCATCGCTCGCCGGCCGGACACTGGTCAACCTGAGCTCTGACACTCCCGACCGTTCACGCGAGGCAGCAACCTGGGCAGCGGGCCACGACGCCACCTTCCTCACCGGAGGTGTCATGGTCCCCGCGCCGATGGTCGGCACGGAGGCAGCCCATGTCTACTACAGCGGCCGCGACCAAGTGATGGAGCGCCACCTGGCGGCGTTGACACTGCTGGGAACACCAAAGTATCTGGGCGAAGACCCGGGCCTCGCCCAGATGATGTATCAAGCCCAGCTCGCGGTGTTCCTCACCACCTTGTCCGGACTCATGCACGCCACCGCGATGCTGGGCACCGCAGGAATGAAGGCCAAGGAAGCGCTGCCGGAGTTGCTCTCCTCCGCCGACTCGATCGGCGACATCCTGAGGGCTGGTGAAGAGAACCCCGGCACCGCGCTTGATGCCGGAGAACATCCCGGCGACCTCAGCACGGTCACGATGATGGGCGCGACATCCGACCACATCGTCGAGACCAGTACGTCACTCGGCCTCGACCTCGCGCTCCCCCTGGCCGTGCAGGCCCACTACCGGCGGGCGATCGAGAACGGACACGGCAGCGACAACTGGACCCGCATCATCGACAGCATCCGAGGACCGCGCTGA	MNEQQNHTTRQDSTVTVIGLGPMGQAMTRTLLTAGHPVTVWNRTAGRADGVVTDGATLAATPSEAVEASDLVILSLTDYQAMYDILGSATASLAGRTLVNLSSDTPDRSREAATWAAGHDATFLTGGVMVPAPMVGTEAAHVYYSGRDQVMERHLAALTLLGTPKYLGEDPGLAQMMYQAQLAVFLTTLSGLMHATAMLGTAGMKAKEALPELLSSADSIGDILRAGEENPGTALDAGEHPGDLSTVTMMGATSDHIVETSTSLGLDLALPLAVQAHYRRAIENGHGSDNWTRIIDSIRGPR	MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV	78.44	gnl|BL_ORD_ID|2277|hsp_num:0	3402			6	288	tigecycline; tetracycline
BGC0000960.1|Azinomycin_50 # 60583 # 62289 # -1 # ID=1_50;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.702	BGC0000960.1|Azinomycin_50 	60583	62289	-	Loose	700	31.5722	tet(D)	36.73	3000168	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGAGTCATGGGGCAGTCGATACTGTGGGGAAGCAAGGCCCCGCCGGATGCCCCGACTTGCCACGCACCCGGTCTCAGCACGAGCACGGAAAGGACACCGGTGGGTAGTAACACTGCTTTCGACAACCGTACGAAGCAGCCGGCCGTTCCACAGCCCCGGCCTCTCATACGCGGCCCGGAGCATCTGGCGGGGGCGCCGGACCGCCACAGCGTCGGACCGATGATGGGGTCCATACAGGCGCTCGCCGGCAACAAGGCCGCGTCCGCCGTCGTCCAGCGTCTCGCGGGGAACGACGAGACGGCGAAGCCCGCCGACGAGCAGGCCAAGCCGGAAGCGAAGAAGAAGTCCCGTACCGGGCTGAACATCCGGGAGCGGATCGCCGGCGCGCTGGAGCGGGCCAACAAGCACCTCGACGTCCTCGACACCTTCGTCCTGCGCGGCATGGTCCCGGCCAACGCGGAGATGAACTGGAAGTCGTCCCAGAACGCCGACACGCACTTTTCGGAGCAGGTCGGCGCGTCCGCCGCAGCGGCCAGTGCCGAGATGGGGCTCACCGACGGGGTCACGGCGGTCAACAACGTCATCGACGCCACCAAGGCGTACAAGGAGTCCAAGCAGAACCCGACGGGTCCCTCCTCCCATGCCCCGCGCAAGAAGTATCCCTCCAAGATGCTCGACGCGATCCAGAACACGGCGACCGACGCCTCCGACTTCATCGGCGTCGCCAGGAACGCTCTGCACGCGGAGGGCCTCGTGACGGCGGCGAGCGTCGCCGAGGCCGGGAGCGGGATGGTCGGCGCCGTCGCGGGCGTCAAGAGCGTCCGTGCGGCGCGCCGGTTCGGGCTGACGACGCGCAAGTACCAGAACGTCAAGAAGATCGACGTGCCCGCGCCGGTGCAGGAGCCCGAGATCAACCGGCTCCACAAGGCGGAGGTGGACAGCCACTGGGCGCTCGCGCAGGCGTATGTCGCGCTGGAGCGTGCCCATGACGGCGACGACGAGGGCCTCGCGGACCGGCTGGGCGCCGCCCTGGACCAGACCGGTGCGGCCTTCACGAGCATCGAGAAGGCCGCCGACGACGTCAAGAAGGCACAGGACACCGTCGCCCTCAACACCGCCCGGGACTACGCGCTGGCGAAGCAGCGCAACAAGCTCTGGAAGCAGGGGGTCGGCGCGGTCGGGGACGGCGTGAGGTCGGCCGGCGGCGCGGTGGCGATCGCAGCGGCTGCCACGGGGACGCTGGCGAGCAACCCGGCCGGCTGGGCGCTGGCCGCGACAGCTGCGGGGCTCCTGCTCTCGGTCACCGCGTACAAGGCCGGGCGCGCCGGCAAGAAGCGTTACGACGGCGCCCGCCACCCCGAGCGCTGGGCCCCGCCCACGGAGGAGGGCGAGCAGACGACAGCCGAGCCCGCCTCCCGCCAGGACGCCCTCAAGGAAGCGCTGAAGTTCTGGAAGAAGGCCGAACACAGCAAGCGCGACGCCATGGCGCGCACCCTCTACGGCCTCGCCGCGGGCCCCGATGTCCCGGCCGGCAAGGGCACCTCGCCCGAACTGCGCACCTCGGCCCGGGAACTGCTCGTCGCGCTGAAGTCGGGCCCCGGGAACCTGCACATGACGGAGGAGGCGTGGGCGGCATCCCTGAACGACCCCGCCGACGCCGAGAAGTGGCACAAGGAGATCGCCAACCAGCTTGCTTCGAGCTGA	MRVMGQSILWGSKAPPDAPTCHAPGLSTSTERTPVGSNTAFDNRTKQPAVPQPRPLIRGPEHLAGAPDRHSVGPMMGSIQALAGNKAASAVVQRLAGNDETAKPADEQAKPEAKKKSRTGLNIRERIAGALERANKHLDVLDTFVLRGMVPANAEMNWKSSQNADTHFSEQVGASAAAASAEMGLTDGVTAVNNVIDATKAYKESKQNPTGPSSHAPRKKYPSKMLDAIQNTATDASDFIGVARNALHAEGLVTAASVAEAGSGMVGAVAGVKSVRAARRFGLTTRKYQNVKKIDVPAPVQEPEINRLHKAEVDSHWALAQAYVALERAHDGDDEGLADRLGAALDQTGAAFTSIEKAADDVKKAQDTVALNTARDYALAKQRNKLWKQGVGAVGDGVRSAGGAVAIAAAATGTLASNPAGWALAATAAGLLLSVTAYKAGRAGKKRYDGARHPERWAPPTEEGEQTTAEPASRQDALKEALKFWKKAEHSKRDAMARTLYGLAAGPDVPAGKGTSPELRTSARELLVALKSGPGNLHMTEEAWAASLNDPADAEKWHKEIANQLASS	MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPLLGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVADSTAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFKPAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWDSAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVYPVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQSADGTVWLIGTALYGLLLAICLLIRKPAPVAATC	144.16	gnl|BL_ORD_ID|1187|hsp_num:0	1138			243	390	tetracycline
BGC0000960.1|Azinomycin_51 # 62942 # 63538 # -1 # ID=1_51;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0000960.1|Azinomycin_51 	62942	63538	-	Loose	390	41.5874	evgA	21.18	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCTGGAGGCGGCCGGCTTCGAGATGTGCGCGCAGGTCGCCGACGCGGAAGGGCTGCTGGCGGCCGTCGAGGAGCACCGGCCCGACATCGCCGTGGTCGACGTGCGCATGCCGCCCGGCTTCACCGACGAGGGAGTACGCGCCGCGCTGGTGATCCGCCGCCAGTACCCGCGTACCGCCGTGCTCCTGCTGTCGCAGTACGTGGAGGAGCGGTACGCCGCCGATCTGCTCGCCGCCAACACCTCGGGCGTCGGCTATCTGCTCAAGCAACGCGTCGCCGACGTGGAGGAGTTCGCCGAGGCGGTACGCCGGGTGGCGGCCGGCGGCACCGCGCTCGACCCGCAGGTCGTCGCGCAGCTGCTGGTGCGCCGGCACAGCGATCCGCTCGACCGGCTCACACCGCGCGAGCGGGAGGTGCTGGAGCTGATGGCGGGCGGCCGGTCCAACTCCGGCATAGCCGCCGAGCTGGTGGTGAGCGAGAGCGCTGTCGCCAAGCACATCAACAGCATTTTCACCAAGCTCGACCTGCCCAGGGCCGACGCCGACCACCGCCGCGTCCTGGCGGTGCTGCGCTTCCTGGGCGTTGCGACCGTGTAG	VLEAAGFEMCAQVADAEGLLAAVEEHRPDIAVVDVRMPPGFTDEGVRAALVIRRQYPRTAVLLLSQYVEERYAADLLAANTSGVGYLLKQRVADVEEFAEAVRRVAAGGTALDPQVVAQLLVRRHSDPLDRLTPREREVLELMAGGRSNSGIAAELVVSESAVAKHINSIFTKLDLPRADADHRRVLAVLRFLGVATV	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	97.06	gnl|BL_ORD_ID|936|hsp_num:0	1015			75	561	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000960.1|Azinomycin_27 # 32735 # 33559 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.720	BGC0000960.1|Azinomycin_27 	32735	33559	+	Loose	500	30.8018	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	23.3	3003393	protein variant model	I194T	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGATGATGCTCGACGGCGACGTCGCCCTGATCACCGGTGCTGCTCGCGCGCTGGGCCGGTCGCACGCGCTGGCCTTCGCCCGCGAGGGCGCGGACCTGATCCTCCTCGACCGCTGCGCCCCCGACGACGGCCCCTACCCGATGGCCGGCCGGCGTGACCTGGAGGAGACCGCGGAAGCCTGCCGAAGGCTCGGCAGCCGCGTCCTGACCGGAGTCGCCGACGTACGCCACCAGGCGGACGTGGACAAGGTGGTGGACGCCGGGCTCGACGCGTTCGGCCGGATCGACGTCCTGCTCAACAACGCGGGCGTCCTCGGTCCCGGCGGCGTCCGCGTACACGAACTCAGCGAGGAACAGTGGCAGTTGGCGCTGGACGTCAACCTGAGCGGCACTTGGCGCACCTGCCGCGCAGTGCTGCCGCACATGGTCGAGCGGGGCGGCGGACGGATCGTCAACACCGCCTCCACCGGCGGACGCGTCGCCTTCGAGCGGTACGCCAACTACGTCGCCTCCAAGCACGGCGTGATCGGACTGACCAAGTCCATCGCGCTGGAGTACGGACGCCACGGCATACGTGCCAACGCGGTCTGTCCCACCACCGTGGCCGACGACGCCGCACTGGGCACCCGCAGCACCCGCGCCGTGGCCGCGTCGATGGGCGCCGAACTGCCCGACTACGAGCGCACGTCGGCGGCGCTGCATCCGATCGGCCGACTGGTCACCGCCGCGGAGGTGTCGGCCGCCTGCCTCTGGCTGGCCGGTGACCGGTCCGGCGGTGTCACCGGCACCGAACTCCTGGTGGACGGCGGCTTCACCGCCCACTGA	MMMLDGDVALITGAARALGRSHALAFAREGADLILLDRCAPDDGPYPMAGRRDLEETAEACRRLGSRVLTGVADVRHQADVDKVVDAGLDAFGRIDVLLNNAGVLGPGGVRVHELSEEQWQLALDVNLSGTWRTCRAVLPHMVERGGGRIVNTASTGGRVAFERYANYVASKHGVIGLTKSIALEYGRHGIRANAVCPTTVADDAALGTRSTRAVAASMGAELPDYERTSAALHPIGRLVTAAEVSAACLWLAGDRSGGVTGTELLVDGGFTAH	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	101.86	gnl|BL_ORD_ID|1964|hsp_num:0	1574			192	789	isoniazid
